false000183003312/312023Q3500.06747640P3DP3Dhttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent00018300332023-01-012023-09-300001830033us-gaap:CommonStockMember2023-01-012023-09-300001830033us-gaap:WarrantMember2023-01-012023-09-300001830033us-gaap:MemberUnitsMember2023-01-012023-09-3000018300332023-11-06xbrli:shares00018300332023-09-30iso4217:USD00018300332022-12-310001830033us-gaap:NonrelatedPartyMember2023-09-300001830033us-gaap:NonrelatedPartyMember2022-12-310001830033us-gaap:RelatedPartyMember2023-09-300001830033us-gaap:RelatedPartyMember2022-12-31iso4217:USDxbrli:shares00018300332023-07-012023-09-3000018300332022-07-012022-09-3000018300332022-01-012022-09-300001830033us-gaap:CommonStockMember2022-12-310001830033us-gaap:AdditionalPaidInCapitalMember2022-12-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001830033us-gaap:RetainedEarningsMember2022-12-310001830033us-gaap:CommonStockMember2023-01-012023-03-310001830033us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100018300332023-01-012023-03-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001830033us-gaap:RetainedEarningsMember2023-01-012023-03-310001830033us-gaap:CommonStockMember2023-03-310001830033us-gaap:AdditionalPaidInCapitalMember2023-03-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001830033us-gaap:RetainedEarningsMember2023-03-3100018300332023-03-310001830033us-gaap:CommonStockMember2023-04-012023-06-300001830033us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000018300332023-04-012023-06-300001830033us-gaap:RetainedEarningsMember2023-04-012023-06-300001830033us-gaap:CommonStockMember2023-06-300001830033us-gaap:AdditionalPaidInCapitalMember2023-06-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001830033us-gaap:RetainedEarningsMember2023-06-3000018300332023-06-300001830033us-gaap:CommonStockMember2023-07-012023-09-300001830033us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001830033us-gaap:RetainedEarningsMember2023-07-012023-09-300001830033us-gaap:CommonStockMember2023-09-300001830033us-gaap:AdditionalPaidInCapitalMember2023-09-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001830033us-gaap:RetainedEarningsMember2023-09-300001830033us-gaap:CommonStockMember2021-12-310001830033us-gaap:AdditionalPaidInCapitalMember2021-12-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001830033us-gaap:RetainedEarningsMember2021-12-3100018300332021-12-310001830033us-gaap:CommonStockMember2022-01-012022-03-310001830033us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018300332022-01-012022-03-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001830033us-gaap:RetainedEarningsMember2022-01-012022-03-310001830033us-gaap:CommonStockMember2022-03-310001830033us-gaap:AdditionalPaidInCapitalMember2022-03-310001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001830033us-gaap:RetainedEarningsMember2022-03-3100018300332022-03-310001830033us-gaap:CommonStockMember2022-04-012022-06-300001830033us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000018300332022-04-012022-06-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001830033us-gaap:RetainedEarningsMember2022-04-012022-06-300001830033us-gaap:CommonStockMember2022-06-300001830033us-gaap:AdditionalPaidInCapitalMember2022-06-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001830033us-gaap:RetainedEarningsMember2022-06-3000018300332022-06-300001830033us-gaap:CommonStockMember2022-07-012022-09-300001830033us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001830033us-gaap:RetainedEarningsMember2022-07-012022-09-300001830033us-gaap:CommonStockMember2022-09-300001830033us-gaap:AdditionalPaidInCapitalMember2022-09-300001830033us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001830033us-gaap:RetainedEarningsMember2022-09-3000018300332022-09-300001830033us-gaap:RelatedPartyMember2023-01-012023-09-300001830033us-gaap:RelatedPartyMember2022-01-012022-09-300001830033us-gaap:NonrelatedPartyMember2023-01-012023-09-300001830033us-gaap:NonrelatedPartyMember2022-01-012022-09-3000018300332021-03-172021-03-1700018300332021-03-17pct:tradingDay0001830033us-gaap:PrivatePlacementMember2022-03-070001830033us-gaap:PrivatePlacementMemberpct:SeriesAWarrantsMember2022-03-070001830033us-gaap:PrivatePlacementMemberus-gaap:CommonStockMember2022-03-172022-03-170001830033us-gaap:PrivatePlacementMemberpct:SeriesAWarrantsMember2022-03-170001830033us-gaap:PrivatePlacementMember2022-03-172022-03-1700018300332022-03-172022-03-170001830033us-gaap:RevolvingCreditFacilityMember2023-03-150001830033pct:IrontonFacilityMember2023-09-300001830033pct:IrontonFacilityMemberus-gaap:SubsequentEventMemberpct:RevenueBondsMember2023-11-08utr:lb0001830033pct:AugustaFacilityMember2023-09-300001830033pct:FeedPrepFacilitiesMember2023-09-30xbrli:pure0001830033us-gaap:NonrelatedPartyMemberpct:RevenueBondsMember2023-09-300001830033us-gaap:NonrelatedPartyMemberpct:RevenueBondsMember2022-12-310001830033us-gaap:NonrelatedPartyMemberpct:EquipmentFinancingPayableMember2023-09-300001830033us-gaap:NonrelatedPartyMemberpct:EquipmentFinancingPayableMember2022-12-310001830033us-gaap:NonrelatedPartyMemberus-gaap:ConvertibleDebtMember2023-09-300001830033us-gaap:NonrelatedPartyMemberus-gaap:ConvertibleDebtMember2022-12-310001830033pct:TermLoanFacilityMemberus-gaap:RelatedPartyMember2023-09-300001830033pct:TermLoanFacilityMemberus-gaap:RelatedPartyMember2022-12-310001830033pct:RevenueBondsMember2020-10-07pct:series0001830033pct:A2020ABondSeriesMaturingDecember12025Memberpct:RevenueBondsMember2020-10-070001830033pct:A2020ABondSeriesMaturingDecember12030Memberpct:RevenueBondsMember2020-10-070001830033pct:A2020ABondSeriesMaturingDecember12042Memberpct:RevenueBondsMember2020-10-070001830033pct:A2020BBondSeriesMaturingDecember12025Memberpct:RevenueBondsMember2020-10-070001830033pct:A2020BBondSeriesMaturingDecember12027Memberpct:RevenueBondsMember2020-10-070001830033pct:RevenueBondsMemberpct:A2020CBondSeriesMaturingDecember12027Member2020-10-070001830033pct:RevenueBondsMember2021-03-170001830033pct:RevenueBondsMember2022-01-310001830033pct:RevenueBondsMember2023-07-012023-09-300001830033pct:RevenueBondsMember2022-07-012022-09-300001830033pct:RevenueBondsMember2023-01-012023-09-300001830033pct:RevenueBondsMember2022-01-012022-09-300001830033pct:RevenueBondsMember2023-09-30pct:supplierpct:purchaser0001830033pct:IrontonFacilityMemberpct:RevenueBondsMember2023-03-150001830033pct:IrontonFacilityMembersrt:MinimumMemberpct:RevenueBondsMember2023-03-15utr:D0001830033pct:CSCLeasingCoMemberpct:EquipmentFinancingPayableMember2023-05-082023-05-080001830033pct:CSCLeasingCoMemberpct:EquipmentFinancingPayableMember2023-05-080001830033pct:CSCLeasingCoMemberpct:EquipmentFinancingPayableMember2023-07-012023-09-300001830033pct:CSCLeasingCoMemberpct:EquipmentFinancingPayableMember2023-01-012023-09-300001830033pct:CSCLeasingCoMemberpct:EquipmentFinancingPayableMember2023-09-300001830033pct:OtherEquipmentFinancingMemberpct:EquipmentFinancingPayableMember2023-09-300001830033us-gaap:RevolvingCreditFacilityMemberpct:DebtInstrumentApplicableMarginPeriodOneMemberpct:SecuredOvernightFinancingRateSOFRMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMemberpct:DebtInstrumentApplicableMarginPeriodTwoMemberpct:SecuredOvernightFinancingRateSOFRMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMemberpct:SecuredOvernightFinancingRateSOFRMemberpct:DebtInstrumentApplicableMarginPeriodThreeMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMemberpct:SecuredOvernightFinancingRateSOFRMemberpct:DebtInstrumentApplicableMarginPeriodFourMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMemberpct:SecuredOvernightFinancingRateSOFRMemberpct:DebtInstrumentApplicableMarginPeriodFiveMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMember2023-03-152023-03-150001830033us-gaap:RevolvingCreditFacilityMember2023-05-080001830033us-gaap:RevolvingCreditFacilityMember2023-08-210001830033us-gaap:RevolvingCreditFacilityMember2023-09-300001830033us-gaap:RevolvingCreditFacilityMember2023-03-162023-09-300001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-05-080001830033pct:TermLoanFacilityMemberpct:SecuredOvernightFinancingRateSOFRMemberpct:PurePlasticTermLoanFacilityMember2023-05-082023-05-080001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-09-300001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-05-082023-05-080001830033pct:TermLoanFacilityMemberpct:DebtInstrumentPrepaymentTermsPeriodOneMemberpct:PurePlasticTermLoanFacilityMember2023-05-082023-05-080001830033pct:TermLoanFacilityMemberpct:DebtInstrumentPrepaymentTermsPeriodTwoMemberpct:PurePlasticTermLoanFacilityMember2023-05-082023-05-080001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-07-012023-09-300001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-01-012023-09-300001830033pct:TermLoanFacilityMemberpct:PurePlasticTermLoanFacilityMember2023-08-210001830033us-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-08-210001830033us-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-08-220001830033us-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-08-240001830033srt:AffiliatedEntityMemberus-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-08-240001830033us-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-08-242023-08-240001830033us-gaap:CommonStockMember2023-08-210001830033us-gaap:ConvertibleDebtMemberpct:GreenConvertibleSeniorNotesDue2030Member2023-06-302023-06-300001830033us-gaap:ConvertibleDebtMember2023-07-012023-09-300001830033us-gaap:ConvertibleDebtMember2022-07-012022-09-300001830033us-gaap:ConvertibleDebtMember2023-01-012023-09-300001830033us-gaap:ConvertibleDebtMember2022-01-012022-09-300001830033us-gaap:ConvertibleDebtMember2023-09-300001830033us-gaap:ConvertibleDebtMember2022-09-30pct:vote0001830033pct:A2021EquityAndIncentiveCompensationPlanMember2021-03-170001830033pct:A2021EquityAndIncentiveCompensationPlanMember2023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2021-12-310001830033us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001830033us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2022-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2022-12-310001830033us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001830033us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001830033us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001830033us-gaap:EmployeeStockOptionMember2022-01-012022-09-3000018300332021-01-012021-12-3100018300332022-01-012022-12-310001830033us-gaap:PerformanceSharesMember2023-01-012023-09-300001830033us-gaap:PerformanceSharesMember2022-01-012022-09-300001830033us-gaap:PerformanceSharesMember2021-12-310001830033us-gaap:PerformanceSharesMember2021-01-012021-12-310001830033us-gaap:PerformanceSharesMember2022-09-300001830033us-gaap:PerformanceSharesMember2022-12-310001830033us-gaap:PerformanceSharesMember2022-01-012022-12-310001830033us-gaap:PerformanceSharesMember2023-09-300001830033us-gaap:CommonStockMember2022-03-172022-03-170001830033us-gaap:CommonStockMember2021-12-310001830033us-gaap:CommonStockMember2021-01-012021-12-310001830033us-gaap:CommonStockMember2022-01-012022-09-300001830033us-gaap:CommonStockMember2022-09-300001830033us-gaap:CommonStockMember2022-12-310001830033us-gaap:CommonStockMember2022-01-012022-12-310001830033us-gaap:CommonStockMember2023-01-012023-09-300001830033us-gaap:CommonStockMember2023-09-300001830033us-gaap:CommonStockMember2023-07-012023-09-300001830033us-gaap:CommonStockMember2022-07-012022-09-300001830033pct:PublicWarrantsAndPrivateWarrantsMember2021-03-172021-03-170001830033pct:PublicWarrantMember2023-09-300001830033pct:PrivateWarrantMember2022-09-300001830033pct:PrivateWarrantMember2023-07-012023-09-300001830033pct:PrivateWarrantMember2023-01-012023-09-300001830033pct:PrivateWarrantMember2022-07-012022-09-300001830033pct:PrivateWarrantMember2022-01-012022-09-300001830033pct:SeriesAWarrantsMember2022-03-172022-03-170001830033pct:SeriesAWarrantsMember2022-03-170001830033us-gaap:MeasurementInputOptionVolatilityMemberpct:SeriesAWarrantsMember2023-09-300001830033pct:SeriesAWarrantsMember2023-09-300001830033pct:SeriesAWarrantsMember2023-07-012023-09-300001830033pct:SeriesAWarrantsMember2023-01-012023-09-300001830033pct:SeriesAWarrantsMember2022-07-012022-09-300001830033pct:SeriesAWarrantsMember2022-01-012022-09-300001830033us-gaap:WarrantMember2023-07-012023-09-300001830033us-gaap:WarrantMember2022-07-012022-09-300001830033us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001830033us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001830033us-gaap:PerformanceSharesMember2023-07-012023-09-300001830033us-gaap:PerformanceSharesMember2022-07-012022-09-300001830033pct:ContingentlyIssuableSharesMember2023-07-012023-09-300001830033pct:ContingentlyIssuableSharesMember2022-07-012022-09-300001830033us-gaap:ConvertibleDebtSecuritiesMember2023-07-012023-09-300001830033us-gaap:ConvertibleDebtSecuritiesMember2022-07-012022-09-300001830033us-gaap:WarrantMember2023-01-012023-09-300001830033us-gaap:WarrantMember2022-01-012022-09-300001830033us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001830033us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001830033us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001830033us-gaap:PerformanceSharesMember2023-01-012023-09-300001830033us-gaap:PerformanceSharesMember2022-01-012022-09-300001830033pct:ContingentlyIssuableSharesMember2023-01-012023-09-300001830033pct:ContingentlyIssuableSharesMember2022-01-012022-09-300001830033us-gaap:ConvertibleDebtSecuritiesMember2023-01-012023-09-300001830033us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-09-300001830033us-gaap:BuildingMember2023-09-300001830033us-gaap:MachineryAndEquipmentMember2023-09-300001830033us-gaap:LeaseholdImprovementsMember2023-09-300001830033us-gaap:FurnitureAndFixturesMember2023-09-300001830033us-gaap:LandImprovementsMember2023-09-300001830033us-gaap:LandMember2023-09-300001830033us-gaap:ConstructionInProgressMember2023-09-300001830033us-gaap:BuildingMember2022-12-310001830033us-gaap:MachineryAndEquipmentMember2022-12-310001830033us-gaap:LeaseholdImprovementsMember2022-12-310001830033us-gaap:FurnitureAndFixturesMember2022-12-310001830033us-gaap:LandImprovementsMember2022-12-310001830033us-gaap:LandMember2022-12-310001830033us-gaap:ConstructionInProgressMember2022-12-310001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ProctorGambleMember2015-10-16pct:phasepct:employee0001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ProctorGambleMember2019-04-300001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ProctorGambleMember2023-03-270001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ProctorGambleMember2023-09-300001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ProctorGambleMember2022-12-310001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ImpactRecyclingLimitedMember2019-11-132019-11-130001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ImpactRecyclingLimitedMember2020-01-012020-12-310001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:ImpactRecyclingLimitedMember2021-01-012021-12-310001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:TotalPetrochemicalsRefiningSANVMember2020-06-232020-06-230001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:NestleLtdMember2018-12-130001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:NestleLtdMember2018-12-132018-12-130001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:NestleLtdMember2023-09-300001830033us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMemberpct:NestleLtdMember2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:USTreasuryNotesSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:MunicipalBondsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberpct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001830033us-gaap:FairValueInputsLevel2Memberpct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberpct:SeriesAWarrantsMember2023-09-300001830033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMember2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMember2023-09-300001830033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberpct:SeriesAWarrantsMember2022-12-310001830033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMember2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:FairValueMeasurementsRecurringMemberpct:SeriesAWarrantsMember2022-12-310001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033us-gaap:MeasurementInputOptionVolatilityMemberpct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:MeasurementInputOptionVolatilityMemberpct:PrivateWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:PrivateWarrantMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:PrivateWarrantMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:PrivateWarrantMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:PrivateWarrantMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-09-300001830033pct:RTIWarrantMemberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:MeasurementInputOptionVolatilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:MeasurementInputOptionVolatilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033pct:RTIWarrantMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMember2023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueInputsLevel3Member2022-12-310001830033pct:RTIWarrantMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-09-300001830033pct:RTIWarrantMemberus-gaap:FairValueInputsLevel3Member2023-09-300001830033us-gaap:FairValueInputsLevel2Memberpct:SeriesAWarrantsMember2022-03-170001830033us-gaap:CommercialPaperMember2023-09-300001830033us-gaap:USTreasuryNotesSecuritiesMember2023-09-300001830033us-gaap:CorporateBondSecuritiesMember2023-09-300001830033us-gaap:MunicipalBondsMember2023-09-300001830033us-gaap:CommercialPaperMember2022-12-310001830033us-gaap:CorporateBondSecuritiesMember2022-12-310001830033us-gaap:MunicipalBondsMember2022-12-310001830033us-gaap:SuretyBondMember2023-03-140001830033us-gaap:SuretyBondMember2023-03-142023-03-1400018300332021-05-11pct:classAction0001830033pct:DenhamBlytheArbitrationMember2023-06-162023-06-160001830033pct:OtherMattersMemberus-gaap:SubsequentEventMember2023-10-06pct:book0001830033pct:OtherMattersMemberus-gaap:SubsequentEventMember2023-10-27pct:stockholder0001830033pct:RealEstateEquipmentAndVehiclesMember2023-09-300001830033pct:RealEstateEquipmentAndVehiclesMembersrt:MinimumMember2023-09-300001830033srt:MaximumMemberpct:RealEstateEquipmentAndVehiclesMember2023-09-3000018300332022-08-2400018300332023-01-31iso4217:EURutr:acre
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2023
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-40234
PureCycle Technologies, Inc.
(Exact name of registrant as specified in its charter)
| | | | | | | | |
Delaware | | 86-2293091 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
5950 Hazeltine National Drive, Suite 300
Orlando, Florida 32822
(877) 648-3565
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbols | | Name of each exchange on which registered |
Common Stock, par value $0.001 per share | | PCT | | The Nasdaq Stock Market LLC |
Warrants, each exercisable for one share of common stock, $0.001 par value per share, at an exercise price of $11.50 per share | | PCTTW | | The Nasdaq Stock Market LLC |
Units, each consisting of one share of common stock, $0.001 par value per share, and three quarters of one warrant | | PCTTU | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of November 6, 2023, there were approximately 164,059,311 shares of the registrant's common stock, par value $0.001 per share, outstanding.
PureCycle Technologies, Inc.
QUARTERLY REPORT on FORM 10-Q
TABLE OF CONTENTS
| | | | | |
| Page |
PART I - Financial Information | |
| |
Item 1. Financial Statements | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
PureCycle Technologies, Inc.
PART I - FINANCIAL INFORMATION
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements about the financial condition, results of operations, earnings outlook and prospects of PureCycle Technologies, Inc. (“PCT”). Forward-looking statements generally relate to future events or PCT’s future financial or operating performance and may refer to projections and forecasts. Forward-looking statements are typically identified by words such as “plan,” “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict,” “should,” “would” and other similar words and expressions (or the negative versions of such words or expressions), but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements are based on the current expectations of the management of PCT and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of this Quarterly Report on Form 10-Q. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section of PCT’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Annual Report on Form 10-K”) entitled “Risk Factors,” those discussed and identified in other public filings made with the U.S. Securities and Exchange Commission (the “SEC”) by PCT and the following:
• PCT's ability to obtain funding for its operations and future growth and to continue as a going concern;
• PCT's ability to meet, and to continue to meet, applicable regulatory requirements for the use of PCT’s UPR resin (as defined below) in food grade applications (including in the United States, Europe, Asia and other future international locations);
• PCT's ability to comply on an ongoing basis with the numerous regulatory requirements applicable to the UPR resin and PCT’s facilities (including in the United States, Europe, Asia and other future international locations);
• expectations and changes regarding PCT’s strategies and future financial performance, including its future business plans, expansion plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and PCT’s ability to invest in growth initiatives;
• the ability of PCT’s first commercial-scale recycling facility in Lawrence County, Ohio (the “Ironton Facility”) to be appropriately certified by Leidos (as defined below), following certain performance and other tests, and commence full-scale commercial operations in a timely and cost-effective manner;
• PCT’s ability to meet, and to continue to meet, the requirements imposed upon it and its subsidiaries by the funding for its operations, including the funding for the Ironton Facility;
• PCT’s ability to complete the necessary funding with respect to, and complete the construction of, (i) its first U.S. multi-line facility, located in Augusta, Georgia (the “Augusta Facility”); (ii) its first commercial-scale European plant located in Antwerp, Belgium and (iii) its first commercial-scale Asian plant located in Ulsan, South Korea, in a timely and cost-effective manner;
• PCT’s ability to sort and process polypropylene plastic waste at its plastic waste prep (“Feed PreP”) facilities;
• PCT’s ability to maintain exclusivity under the Procter & Gamble Company (“P&G”) license (as described below);
• the implementation, market acceptance and success of PCT’s business model and growth strategy;
PureCycle Technologies, Inc.
PART I - FINANCIAL INFORMATION — CONTINUED
• the success or profitability of PCT’s offtake arrangements;
• the ability to source feedstock with a high polypropylene content at a reasonable cost;
• PCT’s future capital requirements and sources and uses of cash;
• developments and projections relating to PCT’s competitors and industry;
• the outcome of any legal or regulatory proceedings to which PCT is, or may become, a party including the securities class action case;
• geopolitical risk and changes in applicable laws or regulations;
• the possibility that PCT may be adversely affected by other economic, business, and/or competitive factors, including rising interest rates, availability of capital, economic cycles, and other macro-economic impacts;
• turnover or increases in employees and employee-related costs;
• changes in the prices and availability of labor (including labor shortages), transportation and materials, including significant inflation, supply chain conditions and its related impact on energy and raw materials, and PCT’s ability to obtain them in a timely and cost-effective manner;
• any business disruptions due to political or economic instability, pandemics, armed hostilities (including the ongoing conflict between Russia and Ukraine and the current situation in Israel);
• the potential impact of climate change on PCT, including physical and transition risks, higher regulatory and compliance costs, reputational risks, and availability of capital on attractive terms; and
• operational risk.
PCT undertakes no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law.
Should one or more of these risks or uncertainties materialize or should any of the assumptions made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events.
PureCycle Technologies, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
| | | | | | | | | | | |
ASSETS |
| (Unaudited) | | |
(in thousands) | September 30, 2023 | | December 31, 2022 |
CURRENT ASSETS | | | |
Cash and cash equivalents | $ | 199,349 | | | $ | 63,892 | |
Debt securities available for sale | 12,026 | | | 98,592 | |
Restricted cash – current | 33,277 | | | 68,850 | |
Prepaid expenses and other current assets | 12,689 | | | 4,883 | |
Total current assets | 257,341 | | | 236,217 | |
Restricted cash – non-current | 151,513 | | | 94,781 | |
Prepaid expenses and other non-current assets | 7,004 | | | 5,483 | |
Operating lease right-of-use assets | 30,050 | | | 19,136 | |
Property, plant and equipment, net | 625,925 | | | 505,719 | |
TOTAL ASSETS | $ | 1,071,833 | | | $ | 861,336 | |
| | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY |
| | | |
CURRENT LIABILITIES | | | |
Accounts payable | $ | 6,847 | | | $ | 1,667 | |
Accrued expenses | 29,824 | | | 35,102 | |
Current portion of long-term debt | 7,065 | | | — | |
Accrued interest | 8,230 | | | 1,532 | |
Total current liabilities | 51,966 | | | 38,301 | |
NON-CURRENT LIABILITIES | | | |
Deferred revenue | 5,000 | | | 5,000 | |
Long-term debt, less current portion | 468,317 | | | 233,513 | |
Related party note payable | 38,029 | | | — | |
Warrant liability | 38,214 | | | 55,883 | |
Operating lease right-of-use liabilities | 27,556 | | | 16,620 | |
Other non-current liabilities | 1,185 | | | 1,136 | |
TOTAL LIABILITIES | $ | 630,267 | | | $ | 350,453 | |
| | | |
COMMITMENT AND CONTINGENCIES | | | |
| | | |
STOCKHOLDERS' EQUITY | | | |
Common shares - $0.001 par value, 450,000 shares authorized; 164,059 and 163,550 shares issued and outstanding as of September 30, 2023 and December 31, 2022 | $ | 164 | | | $ | 164 | |
Additional paid-in capital | 761,466 | | | 753,885 | |
Accumulated other comprehensive loss | (7) | | | (641) | |
Accumulated deficit | (320,057) | | | (242,525) | |
TOTAL STOCKHOLDERS' EQUITY | 441,566 | | | 510,883 | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 1,071,833 | | | $ | 861,336 | |
The accompanying notes are an integral part of these financial statements.
PureCycle Technologies, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
| | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, |
| 2023 | 2022 | | 2023 | 2022 |
(in thousands except per share data) | | | | | |
Costs and expenses | | | | | |
Operating costs | $ | 21,897 | | $ | 6,451 | | | $ | 44,413 | | $ | 16,948 | |
Research and development | 178 | | 254 | | | 731 | | 843 | |
Selling, general and administrative | 13,172 | | 14,382 | | | 39,725 | | 42,083 | |
Total operating costs and expenses | 35,247 | | 21,087 | | | 84,869 | | 59,874 | |
Interest expense | 10,750 | | 159 | | | 14,883 | | 1,197 | |
Interest income | (2,117) | | (1,261) | | | (5,077) | | (2,031) | |
Change in fair value of warrants | (48,817) | | 14,884 | | | (17,669) | | 16,224 | |
Other expense | 51 | | 79 | | | 526 | | 120 | |
Total other (income) expense | (40,133) | | 13,861 | | | (7,337) | | 15,510 | |
Net income (loss) | $ | 4,886 | | $ | (34,948) | | | $ | (77,532) | | $ | (75,384) | |
Earnings (loss) per share | | | | | |
Basic | $ | 0.03 | | $ | (0.21) | | | $ | (0.47) | | $ | (0.49) | |
Diluted | $ | 0.00 | | $ | (0.21) | | | $ | (0.48) | | $ | (0.49) | |
Weighted average common shares | | | | | |
Basic | 164,018 | | 163,490 | | | 163,783 | | 153,513 | |
Diluted | 165,548 | | 163,490 | | | 163,980 | | 153,699 | |
| | | | | |
Other comprehensive income (loss) | | | | | |
Unrealized (loss) gain on debt securities available for sale | (7) | | 14 | | | 634 | | (800) | |
Total comprehensive income (loss) | $ | 4,879 | | $ | (34,934) | | | $ | (76,898) | | $ | (76,184) | |
The accompanying notes are an integral part of these financial statements.
PureCycle Technologies, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Three and Nine Months Ended September 30, 2023 |
| Common stock | | | | | | | | |
(in thousands) | Shares | | Amount | | Additional paid-in capital | | Accumulated other comprehensive loss | | Accumulated deficit | | Total stockholders' equity |
Balance, December 31, 2022 | 163,550 | | | $ | 164 | | | $ | 753,885 | | | $ | (641) | | | $ | (242,525) | | | $ | 510,883 | |
| | | | | | | | | | | |
Share repurchase | (48) | | | — | | | (277) | | | — | | | — | | | (277) | |
Equity-based compensation | 169 | | | — | | | 2,166 | | | — | | | — | | | 2,166 | |
Unrealized gain on available for sale debt securities | — | | | — | | | — | | | 641 | | | — | | | 641 | |
Net loss | — | | | — | | | — | | | — | | | (25,842) | | | (25,842) | |
Balance, March 31, 2023 | 163,671 | | | $ | 164 | | | $ | 755,774 | | | $ | — | | | $ | (268,367) | | | $ | 487,571 | |
Share repurchase | (9) | | | — | | | (27) | | | — | | | — | | | (27) | |
Forfeiture of restricted stock | (1) | | | — | | | — | | | — | | | — | | | — | |
Equity-based compensation | 135 | | | — | | | 3,252 | | | — | | | — | | | 3,252 | |
| | | | | | | | | | | |
Net loss | — | | | — | | | — | | | — | | | (56,576) | | | (56,576) | |
Balance, June 30, 2023 | 163,796 | | | $ | 164 | | | $ | 758,999 | | | $ | — | | | $ | (324,943) | | | $ | 434,220 | |
| | | | | | | | | | | |
Share repurchase | (78) | | | — | | | (818) | | | — | | | — | | | (818) | |
| | | | | | | | | | | |
Equity based compensation | 341 | | | — | | | 3,285 | | | — | | | — | | | 3,285 | |
Unrealized loss on available-for-sale debt securities | — | | | — | | | — | | | (7) | | | — | | | (7) | |
Net Income | — | | | — | | | — | | | — | | | 4,886 | | | 4,886 | |
Balance at September 30, 2023 | 164,059 | | | $ | 164 | | | $ | 761,466 | | | $ | (7) | | | $ | (320,057) | | | $ | 441,566 | |
PureCycle Technologies, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| For the Three and Nine Months Ended September 30, 2022 |
| Common stock | | | | | | | | |
(in thousands) | Shares | | Amount | | Additional paid-in capital | | Accumulated other comprehensive loss | | Accumulated deficit | | Total stockholders' equity |
Balance, December 31, 2021 | 127,647 | | | $ | 128 | | | $ | 539,423 | | | $ | (237) | | | $ | (157,779) | | | $ | 381,535 | |
Issuance of common stock | 35,714 | | | 35 | | | 205,261 | | | — | | | — | | | 205,296 | |
Share repurchase | (130) | | | — | | | (1,049) | | | — | | | — | | | (1,049) | |
Equity-based compensation | 3 | | | — | | | 3,171 | | | — | | | — | | | 3,171 | |
Unrealized loss on available for sale debt securities | — | | | — | | | — | | | (340) | | | — | | | (340) | |
Net loss | — | | | — | | | — | | | — | | | (25,432) | | | (25,432) | |
Balance, March 31, 2022 | 163,234 | | | $ | 163 | | | $ | 746,806 | | | $ | (577) | | | $ | (183,211) | | | $ | 563,181 | |
| | | | | | | | | | | |
Share repurchase | (2) | | | — | | | (17) | | | — | | | — | | | (17) | |
Equity-based compensation | 50 | | | — | | | 3,267 | | | — | | | — | | | 3,267 | |
Unrealized loss on available for sale debt securities | — | | | — | | | — | | | (460) | | | — | | | (460) | |
Net loss | — | | | — | | | — | | | — | | | (15,004) | | | (15,004) | |
Balance, June 30, 2022 | 163,282 | | | $ | 163 | | | $ | 750,056 | | | $ | (1,037) | | | $ | (198,215) | | | $ | 550,967 | |
| | | | | | | | | | | |
Share repurchase | (71) | | | — | | | (506) | | | — | | | — | | | (506) | |
| | | | | | | | | | | |
Equity based compensation | 298 | | 1 | | 3,009 | | | — | | | — | | | 3,010 | |
Unrealized gain on available-for-sale debt securities | — | | | — | | | — | | | 14 | | | — | | | 14 | |
Net loss | — | | | — | | | — | | | — | | | (34,948) | | | (34,948) | |
Balance at September 30, 2022 | 163,509 | | | $ | 164 | | | $ | 752,559 | | | $ | (1,023) | | | $ | (233,163) | | | $ | 518,537 | |
The accompanying notes are an integral part of these financial statements.
PureCycle Technologies, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| | | | | | | | | | | |
| Nine months ended September 30, |
(in thousands) | 2023 | | 2022 |
Cash flows from operating activities | | | |
Net loss | $ | (77,532) | | | $ | (75,384) | |
Adjustments to reconcile net loss to net cash used in operating activities | | |
|
Equity-based compensation | 8,703 | | | 9,448 | |
Fair value change of warrants | (17,669) | | | 16,224 | |
Depreciation expense | 14,618 | | | 2,583 | |
Amortization of debt issuance costs and debt discounts | 1,840 | | | 746 | |
Accretion of discount on debt securities | (149) | | | (235) | |
Operating lease amortization expense | 2,171 | | | 964 | |
| | | |
| | | |
Changes in operating assets and liabilities | | | |
Prepaid expenses and other current assets | (5,957) | | | (3,320) | |
Prepaid expenses and other non-current assets | (1,523) | | | (1,296) | |
Accounts payable | 1,527 | | | 827 | |
Accrued expenses | 4,375 | | | 491 | |
Accrued interest | 9,867 | | | 324 | |
| | | |
Operating right-of-use liabilities | (1,601) | | | (1,536) | |
Net cash used in operating activities | $ | (61,330) | | | $ | (50,164) | |
Cash flows from investing activities | | | |
Purchase of property, plant & equipment | (142,680) | | | (212,095) | |
Purchase of debt securities, available for sale | (12,020) | | | (192,388) | |
Sale and maturity of debt securities, available for sale | 99,371 | | | 200,689 | |
Net cash used in investing activities | $ | (55,329) | | | $ | (203,794) | |
Cash flows from financing activities | | | |
Proceeds from issuance of convertible notes | 225,000 | | | — | |
Proceeds from related party note payable | 38,000 | | | — | |
Proceeds from equipment lease financing | 22,101 | | | — | |
Convertible notes issuance costs | (6,498) | | | — | |
Related party note payable issuance costs | (2,100) | | | — | |
Debt issuance costs | (1,849) | | | — | |
Payments to repurchase shares | (1,122) | | | (1,572) | |
Other payments for financing activities | (257) | | | (36) | |
Proceeds from issuance of common stock | — | | | 206,072 | |
Proceeds from issuance of warrants | — | | | 43,929 | |
Common stock issuance costs | — | | | (775) | |
Net cash provided by financing activities | $ | 273,275 | | | $ | 247,618 | |
Net increase (decrease) in cash and restricted cash | 156,616 | | | (6,340) | |
Cash and restricted cash, beginning of period | 227,523 | | | 263,858 | |
Cash and restricted cash, end of period | $ | 384,139 | | | $ | 257,518 | |
Supplemental disclosure of cash flow information | | | |
| | | |
Interest paid during the period, net of capitalized interest | $ | 2,736 | | | $ | 650 | |
Non-cash investing activities | | | |
Additions to property, plant, and equipment in accrued expenses | $ | 16,152 | | | $ | 22,059 | |
Additions to property, plant, and equipment in accounts payable | $ | 4,470 | | | $ | 3,267 | |
Additions to property, plant, and equipment in accrued interest | $ | — | | | $ | 4,271 | |
Non-cash financing activities | | | |
PIK interest on related party note payable | $ | 1,745 | | | $ | — | |
| | | |
| | | |
| | | |
| | | |
The accompanying notes are an integral part of these financial statements.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 - ORGANIZATION
Formation and Organization
PureCycle Technologies, Inc. (“PCT” or “Company”) is a Florida-based corporation focused on commercializing a patented purification recycling technology (the “Technology”), originally developed by The Procter & Gamble Company (“P&G”), for restoring waste polypropylene into resin, called ultra-pure recycled (“UPR”) resin, which has nearly identical properties and applicability for reuse as virgin polypropylene. PCT has a global license for the Technology from P&G. PCT’s goal is to create an important new segment of the global polypropylene market that will assist multinational entities in meeting their sustainability goals, providing consumers with polypropylene-based products that are sustainable, and reducing overall polypropylene waste in the world’s landfills and oceans.
Business Combination
On March 17, 2021, PureCycle consummated the previously announced business combination (“Business Combination”) by and among Roth CH Acquisition I Co., a Delaware corporation (“ROCH”), Roth CH Acquisition I Co. Parent Corp., a Delaware corporation and wholly owned direct subsidiary of ROCH (“ParentCo”), Roth CH Merger Sub LLC, a Delaware limited liability company and wholly owned direct subsidiary of Parent Co, Roth CH Merger Sub Corp., a Delaware corporation and wholly owned direct subsidiary of ParentCo and PureCycle Technologies LLC (“PCT LLC” or “Legacy PCT”) pursuant to the Agreement and Plan of Merger dated as of November 16, 2020, as amended from time to time (the “Merger Agreement”).
Upon the completion of the Business Combination and the other transactions contemplated by the Merger Agreement (the “Transactions”, and such completion, the “Closing”), ROCH changed its name to PureCycle Technologies Holdings Corp. and became a wholly owned direct subsidiary of ParentCo, PCT LLC became a wholly owned direct subsidiary of PureCycle Technologies Holdings Corp. and a wholly owned indirect subsidiary of ParentCo, and ParentCo changed its name to PureCycle Technologies, Inc. The Company’s common stock, units and warrants are now listed on the Nasdaq Capital Market (“NASDAQ”) under the symbols “PCT,” “PCTTU” and “PCTTW,” respectively.
Legacy PCT unitholders will be issued up to 4.0 million additional shares of the Company’s common stock if certain conditions are met (“the Earnout”). The Legacy PCT unitholders will be entitled to 2.0 million shares if after 1 year after the Closing and prior to or as of the third anniversary of the Closing, the closing price of the common stock is greater than or equal to $18.00 over any 20 trading days within any 30-trading day period. The Legacy PCT unitholders will also be entitled to 2.0 million shares upon the Ironton Facility becoming operational, as certified by Leidos Engineering, LLC (“Leidos”), an independent engineering firm, in accordance with criteria established in agreements in connection with construction of the plant.
Unless the context otherwise requires, “Registrant,” “PureCycle,” “Company,” “PCT,” “we,” “us,” and “our” refer to PureCycle Technologies, Inc., and its subsidiaries at and after the Closing and give effect to the Closing. “Legacy PCT”, “ROCH” and “ParentCo” refer to PureCycle Technologies LLC, ROCH and ParentCo, respectively, prior to the Closing.
Private Placement Offering
On March 7, 2022, the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “2022 PIPE Investors”), pursuant to which the Company agreed to sell to the Investors, in a private placement, shares of the Company’s common stock, par value $0.001 per share, and Series A warrants to purchase shares of Common Stock (the “Series A Warrants”) at a price of $7.00 per share of Common Stock and one-half (1/2) of one Series A Warrant (the “2022 PIPE Offering”).
On March 17, 2022, the Company closed the 2022 PIPE Offering and issued to the 2022 PIPE Investors an aggregate of 35,714,272 shares of Common Stock and Series A Warrants to purchase an aggregate of 17,857,136 shares of Common Stock. The Company received approximately $250.0 million in gross proceeds from the 2022
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
PIPE Offering. The Company incurred approximately $0.8 million of expenses primarily related to advisory fees in conjunction with the 2022 PIPE Offering.
Refer to Note 6 – Warrants for further information.
Basis of Presentation
The accompanying condensed consolidated interim financial statements include the accounts of the Company. The condensed consolidated interim financial statements are presented in U.S. Dollars. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and accounting principles generally accepted in the United States of America (“U.S. GAAP”). Intercompany balances and transactions were eliminated upon consolidation. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the entire year ending December 31, 2023. The accompanying condensed consolidated interim financial statements reflect all adjustments, consisting of normal recurring adjustments, that are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented.
Reclassifications
Certain amounts in prior periods have been reclassified to conform with the report classifications of the nine months ended September 30, 2023 and 2022.
Liquidity and Going Concern
The accompanying consolidated financial statements have been prepared assuming that PCT will continue as a going concern; however, the conditions described below raise substantial doubt about PCT’s ability to do so, which management believes has been alleviated through its plans to mitigate these conditions and obtain additional unrestricted liquidity.
The Company has sustained recurring losses and negative cash flows from operations since its inception. As reflected in the accompanying consolidated financial statements, the Company recently began commercial operations but does not yet have any sources of revenue. Revenue generation is expected later in 2023. The following is a summary of the components of our current liquidity (in thousands):
| | | | | | | | |
| As of |
| September 30, 2023 | December 31, 2022 |
Cash and cash equivalents | $ | 199,349 | | $ | 63,892 | |
Debt securities available for sale | 12,026 | | 98,592 | |
Unrestricted liquidity | 211,375 | | 162,484 | |
Less: Other Ironton set-aside | — | | 54,560 | |
Available unrestricted liquidity | $ | 211,375 | | $ | 107,924 | |
| | |
Restricted Cash (current and non-current) | $ | 184,790 | | $ | 163,631 | |
| | |
Working capital | $ | 205,375 | | $ | 197,916 | |
Accumulated deficit | $ | (320,057) | | $ | (242,525) | |
| | |
| For the nine months ended |
| September 30, 2023 | September 30, 2022 |
Net loss | $ | (77,532) | | $ | (75,384) | |
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
As of September 30, 2023, PCT had $211.4 million of Available Unrestricted Liquidity. On March 15, 2023, PCT entered into a $150.0 million revolving credit facility (the “Revolving Credit Facility”). Borrowings under the Revolving Credit Agreement may be used for working capital, capital expenditures and other general corporate purposes. There are currently no borrowings under the Revolving Credit Facility.
As of September 30, 2023, PCT anticipates that up to $12.5 million will be needed to complete the Ironton Facility, which relates to a performance guarantee payment due after successful completion of a performance testing milestone.
As further described in Note 3 – Notes Payable and Debt Instruments, the Company and its subsidiaries agreed to achieve certain Milestones set forth in the Limited Waiver in connection with the Ironton Facility (terms used as defined below). As of September 30, 2023, the Ironton Facility failed to meet one such Milestone related to certain targeted production and performance targets, specifically, it failed to produce 4.45 million pounds of pellets from its feedstock in a single month by that date (“September Milestone”). This created a Specified Event of Default under the Limited Waiver (the “September Milestone Event of Default”).
On November 8, 2023, the Limited Waiver parties entered into a Limited Waiver and Second Supplemental Indenture (the “Second Limited Waiver”) pursuant to which the September Milestone Event of Default was waived, various Milestones were amended and extended and certain additional requirements were imposed upon PCT and its subsidiaries (as described further in Note 3 – Notes Payable and Debt Instruments). These additional requirements include depositing $50 million of additional collateral to the Trustee Account, which was paid on November 8, 2023.
PCT also has other capital commitments of approximately $24.6 million related to long-lead equipment and pre-construction work for the Augusta Facility and $21.3 million for equipment and leases related to future Feed PreP and purification facilities. There are also ongoing monthly costs associated with managing the company, paying debt service obligations, and preparing the Ironton Facility for revenue generation.
PCT believes that its current level of Liquidity, including the unused Revolving Credit Facility may be sufficient to fund operations and outstanding commitments. However, given the September Milestone Event of Default under the Limited Waiver, and lack of revenue to date, there is substantial doubt regarding PCT’s ability to continue as a going concern for a period of at least one year from the date of issuance of the condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q.
After considering management’s plans to mitigate substantial doubt, including the plant becoming commercially viable and revenue generating later in 2023, PCT believes this substantial doubt has been alleviated and it has sufficient liquidity to continue as a going concern for the next twelve months.
PCT’s future capital requirements will depend on many factors, including the funding mechanism and construction schedule of the Augusta Facility and other anticipated facilities outside the United States, build-out of multiple Feed PreP facilities, funding needs to support other business opportunities, funding for general corporate purposes, and other challenges or unforeseen circumstances. As a pre-revenue operating company, PCT continually reviews its cash outlays, pace of hiring, professional services and other spend, and capital commitments to proactively manage those needs in tandem with its Available Unrestricted Liquidity balance. For future growth and investment, PCT expects to seek additional debt or equity financing from outside sources, which it may not be able to raise on terms favorable to PCT, or at all. If PCT is unable to raise additional debt or sell additional equity when desired, or if PCT is unable to manage its cash outflows, PCT’s business, financial condition, and results of operations would be adversely affected. In addition, any financing arrangement may have potentially adverse effects on PCT and/or its stockholders. Debt financing (if available and undertaken) will increase expenses, must be repaid regardless of operating results or revenue generation, and may involve restrictions limiting PCT’s operating flexibility. If PCT consummates an equity financing to raise additional funds, the percentage ownership of its existing stockholders will be reduced, and the new equity securities may have rights, preferences or privileges senior to those of the current holders of PCT’s common stock.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Going Concern
Refer to Note 1 – Organization for further discussion.
Cash and Cash Equivalents
The Company considers all highly liquid investments with an original maturity of three months or less at date of inception to be cash and cash equivalents. As of September 30, 2023, the Company’s cash and cash equivalents balance represents cash and money market funds deposited with financial institutions, as well as commercial paper and US treasuries with maturities of 90 days or less at acquisition. These balances may exceed federally insured limits; however, the Company believes the risk of loss is low. Actively traded money market funds are measured at their net asset value (“NAV”) and classified as Level 1. The Company’s remaining cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization.
Restricted Cash
Proceeds from the issuance of revenue bonds are restricted for use in construction of the Ironton Facility. Amounts required by the Limited Waiver (refer to Note 3 – Notes Payable and Debt Instruments) were also placed in restricted cash for various future uses. Cash pledged as collateral for leased properties is also deemed restricted and included within this definition. Restricted cash that is expected to be spent or released from restriction within twelve months is classified as current on the consolidated balance sheet. Restricted cash that is expected to be spent or released from restriction after twelve months is classified as non-current on the consolidated balance sheet.
Investments
The Company accounts for its investment in Debt Securities in accordance with ASC 320, Investments – Debt Securities. The fair value for fixed-rate debt securities is based on quoted market prices for the same or similar debt instruments and is classified as Level 2. All investment holdings as of September 30, 2023 and December 31, 2022 were classified as Available for Sale. The Company classifies its Debt Securities investments as current assets as they are highly liquid and the related funds are available for use in current operations.
Income Taxes
To calculate the interim tax provision, at the end of each interim period the Company estimates the annual effective tax rate and applies that to its ordinary quarterly earnings. The effect of changes in the enacted tax laws or rates is recognized in the interim period in which the change occurs. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and judgments including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in other jurisdictions, permanent differences between book and tax amounts, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, additional information is obtained, or the tax environment changes.
Warrants
The Company evaluates all of its financial instruments, including issued warrants, to determine if such instruments are liability classified, pursuant to ASC 480 - Distinguishing Liabilities from Equity (“ASC 480”) or derivatives or contain features that qualify as embedded derivatives pursuant to ASC 815 – Derivatives and Hedging (“ASC 815”). The classification of instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Issuance costs incurred with the Business Combination that are attributable to liability classified warrants are expensed as incurred.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Recently Issued Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments (“ASU 2016-13”), which, together with subsequent amendments, amends the requirement on the measurement and recognition of expected credit losses for financial assets held. The Company adopted the ASU during the first quarter of 2023 using a prospective approach. The adoption of the ASU did not have a material impact on the Company’s condensed consolidated financial statements.
NOTE 3 – NOTES PAYABLE AND DEBT INSTRUMENTS
The Company’s debt balances consist of the following at September 30, 2023 and December 31, 2022:
| | | | | | | | | | | | | | |
| | September 30, 2023 | | December 31, 2022 |
Revenue Bonds | | $ | 249,550 | | | $ | 249,550 | |
Equipment Financing Payable | | 21,911 | | | — | |
Green Convertible Notes | | 250,000 | | | — | |
| | $ | 521,461 | | | $ | 249,550 | |
Less: Original issue discount and debt issuance costs classified as a reduction to long-term debt | | (46,079) | | | (16,037) | |
Less: Current portion | | (7,065) | | | — | |
Long-term debt, less current portion | | $ | 468,317 | | | $ | 233,513 | |
| | | | |
Pure Plastic Note Payable | | $ | 41,745 | | | $ | — | |
Less: Original issue discount and debt issuance costs classified as a reduction to note payable | | (3,716) | | | — | |
Related party note payable | | $ | 38,029 | | | $ | — | |
Revenue Bonds
On October 7, 2020, the Southern Ohio Port Authority (“SOPA”) issued certain revenue bonds (“Revenue Bonds”) pursuant to an Indenture of Trust dated as of October 1, 2020 (as amended, restated, supplemented or otherwise modified from time to time, the “Indenture”), between SOPA and UMB Bank, N.A., as Trustee (“Trustee”), and loaned the proceeds from their sale to PureCycle: Ohio LLC (“PCO”), an Ohio limited liability company and indirect wholly-owned subsidiary of PCT, pursuant to a Loan Agreement dated as of October 1, 2020, between SOPA and PCO (as amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”), to be used to (i) acquire, construct and equip the Ironton Facility (referred to within the Loan Agreement as the “Ohio Phase II Facility” and, together with the FEU (referred to within the Loan Agreement as the “Phase I Facility”), the “Project”); (ii) fund a debt service reserve fund for the Series 2020A Bonds; (iii) finance capitalized interest; and (iv) pay the costs of issuing the Revenue Bonds. The Revenue Bonds were offered in three series, including (i) Exempt Facility Revenue Bonds (PureCycle Project), Tax-Exempt Series 2020A (“Series 2020A Bonds”); (ii) Subordinate Exempt Facility Revenue Bonds (PureCycle Project), Tax-Exempt Series 2020B (“Series 2020B Bonds”); and (iii) Subordinated Exempt Facility Revenue Bonds (PureCycle Project), Taxable Series 2020C (“Series 2020C Bonds”), each series in the aggregate principal amount, bearing interest and maturing as shown in the table below. The Series 2020A Bonds were issued at a total discount of $5.5 million. The discount is amortized over the term of the Revenue Bonds using the effective interest method. The purchase price of the Revenue Bonds was paid and immediately available to SOPA on October 7, 2020, the date of delivery of the Revenue Bonds to their original purchaser. PureCycle is not a direct obligor on the Revenue Bonds and is not a party to the Loan Agreement or the Indenture pursuant to which the Revenue Bonds have been issued. Legacy PCT has executed a guaranty of completion dated as of October 7, 2020 (“Guaranty”), with respect to the full and complete performance by PCO of PCO’s obligations with respect to construction and completion of the Project, including construction by the Completion Date, free and clear of any liens (other than permitted liens), and the payment of all Project costs incurred prior to completion of the Project, and all claims, liabilities, losses and damages owed by PCO to each counterparty under the Project Documents (as such terms are defined in the Indenture). In addition, pursuant to the
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Guaranty, PCT LLC is obligated to fund and maintain a liquidity reserve for the Project during the term of the Guaranty in the amount of $50.0 million to be held in an escrow account with U.S. Bank National Association, as escrow agent (“Liquidity Reserve”). Pursuant to the terms of the Loan Agreement PCO executed promissory notes in the principal amounts of each maturity (or interest rate within a maturity), aggregating the principal amount of each series of Revenue Bonds, in favor of SOPA, which were assigned to the Trustee on October 7, 2020.
| | | | | | | | | | | | | | |
(in thousands) | | | | |
Bond Series | Term | Principal Amount | Interest Rate | Maturity Date |
2020A | A1 | $ | 12,370 | | 6.25 | % | December 1, 2025 |
2020A | A2 | $ | 38,700 | | 6.50 | % | December 1, 2030 |
2020A | A3 | $ | 168,480 | | 7.00 | % | December 1, 2042 |
2020B | B1 | $ | 10,000 | | 10.00 | % | December 1, 2025 |
2020B | B2 | $ | 10,000 | | 10.00 | % | December 1, 2027 |
2020C | C1 | $ | 10,000 | | 13.00 | % | December 1, 2027 |
The proceeds of the Revenue Bonds and certain equity contributions have been placed in various trust funds and non-interest-bearing accounts established and administered by the Trustee under the Indenture. Before each disbursement of amounts in the Project Fund held by the Trustee under the Indenture, PCO is required to submit to the Trustee a requisition for funds to be disbursed outlining the specified purpose of the disbursement and substantiating the expenditure. In addition, 100% of revenue attributable to the production of the Ironton Facility must be deposited into an operating revenue escrow fund held by U.S. Bank Trust Company, National Association, as escrow agent. Funds in the trust accounts and operating revenue escrow fund will be disbursed by the Trustee when certain conditions are met, and will be used to pay costs and expenditures related to the development and operation of the Ironton Facility, make required interest and principal payments (including sinking fund redemption amounts) and pay any premium, in certain circumstances required under the Indenture, to redeem the Revenue Bonds.
As conditions for closing of the Revenue Bonds, Legacy PCT contributed $60.0 million in equity at closing and PureCycle and certain affiliates contributed an additional $40.0 million in equity upon the closing of the Business Combination. PureCycle provided the Liquidity Reserve for construction of the Ironton Facility of $50.0 million and deposited that amount upon the closing of the Business Combination. In addition, PureCycle must maintain $100.0 million of cash on its balance sheet as of January 31, 2022, including the Liquidity Reserve. The Company met these requirements and continues to maintain that cash balance at September 30, 2023.
The Revenue Bonds are recorded within Long-term debt in the condensed consolidated balance sheet. The Company incurred $4.9 million and $4.8 million of interest cost during each of the three months ended September 30, 2023 and 2022, respectively, and $14.6 million and $14.5 million of interest cost during the nine months ended September 30, 2023 and 2022, respectively. As the Revenue Bond proceeds are being used to construct the Company’s property, plant and equipment, the interest costs related to the tax-exempt portion of the Revenue Bonds have been capitalized within property, plant and equipment until the construction was complete in June 2023. The Company capitalized $0 and $4.2 million of interest cost during each of the three months ended September 30, 2023 and 2022, respectively, and $7.1 million and $12.8 million of interest cost during the nine months ended September 30, 2023 and 2022. As of September 30, 2023 the fair value of the Revenue Bonds was $169.4 million, which was determined using inputs characteristic of a Level 2 fair value measurement. Although the Company has determined the estimated fair value using available market information and commonly accepted valuation methodologies, considerable judgement is required in interpreting the information and in developing the estimated fair value. Therefore, this estimate is not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange.
In connection with its obligations under that certain Security Agreement dated as of October 7, 2020, between PCO, as debtor, and the Trustee, as secured party, entered into when the Revenue Bonds were issued (the “Security Agreement”), PCO must deliver consent and agreements (“Consents”) to the Trustee with respect to each agreement entered into in connection with the Project, each of which agreements is required under the Loan
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Agreement to be assigned to the Trustee. The forms of the Consents relating to a certain feedstock supply agreement from one supplier of feedstock to the Project (the “Supplier”) and from two purchasers of offtake from the Project (“Offtaker 2” and “Offtaker 3” and together with the Supplier, the “Counterparties”) delivered to the Trustee contained terms inconsistent with the form of the Consent required under the Security Agreement. On May 11, 2021, the Guaranty was amended and restated in an amended and restated guaranty of completion (the “ARG”) executed by PureCycle and delivered to the Trustee, which broadens the purposes for which draws by the Trustee on the Liquidity Reserve may be utilized, extends the period during which the Liquidity Reserve must be maintained, includes conditions that would permit a reduction in the amount of the Liquidity Reserve required to be maintained by PureCycle, and includes conditions precedent to the elimination of the requirement that PureCycle replenish the Liquidity Reserve and to the termination of the ARG and the escrow agreement under which the Liquidity Reserve is held by the escrow agent (the “Escrow Agreement”), upon which termination, the balance of the Liquidity Reserve will be returned to PureCycle. So long as there are any Series 2020A Bonds outstanding under the Indenture, the ARG and the Escrow Agreement will remain in place upon the conditions stated in the ARG. The terms of the ARG are summarized as follows: The Liquidity Reserve shall be maintained in the amount of $50.0 million, subject to replenishment by PureCycle until certain conditions stated in the ARG relating to the following have been met: (i) the completion of construction and acquisition of the Project, (ii) the payment of all Project costs, and (iii) the replacement of the assigned agreements of the Counterparties underlying the Consents which have expired or terminated, with one or more agreements between counterparties and PCO upon terms at least as favorable to PCO as the expired or terminated agreements of the Counterparties, (a) for which a Consent that conforms to the form of Consent required by the Security Agreement is executed by the counterparties and provided to the Trustee, (b) which, in the case of supply of feedstock to the Project, provide in the aggregate for the supply of at least the minimum and maximum volumes of feedstock meeting substantially similar feedstock specifications as the Supplier had committed to supply, and (c) which, in the case of purchase of offtake from the Project, provide in the aggregate for the purchase of the minimum and maximum volumes of offtake from the Project meeting substantially similar specifications as Offtaker 2 and Offtaker 3 had committed to purchase from PCO. When the conditions stated in (i), (ii) and (iii) above have been satisfied but so long as there are Series 2020A Bonds outstanding under the Indenture, the Escrow Agreement shall remain in place but the Liquidity Reserve amount shall be reduced to $25.0 million and PureCycle shall no longer be required to replenish the amount of the reduced Liquidity Reserve if and when disbursements are made therefrom. If the conditions of (i) and (ii) have been met but only a portion of the feedstock and offtake contracted for by the Counterparties, respectively, has been replaced under replacement agreements as aforesaid in (iii) above, then the Liquidity Reserve amount may be reduced only by the applicable proportion of the amounts stated in the ARG which evidence the intent of the parties of the amount of value representing the supply or offtake of the agreements of the Counterparties. When the conditions precedent of (i), (ii), and (iii) have been satisfied and there are no longer any Series 2020A Bonds then outstanding, then PureCycle shall have no obligation to maintain the reduced Liquidity Reserve, the ARG and the Escrow Agreement shall terminate and the balance on deposit in the Liquidity Reserve escrow fund held by the escrow agent shall be returned to PureCycle.
As long as any Series 2020A Bonds remain outstanding under the Indenture, upon the occurrence of an Event of Default under the Loan Agreement or Indenture, if the Trustee takes control of the Liquidity Reserve held by the escrow agent, such funds may be used for any purpose, including the payment of debt service on the Series 2020A Bonds, as may be determined by the Trustee or directed by a majority of the holders of the Series 2020A Bonds then outstanding.
On March 15, 2023, PCT LLC, PCTO Holdco LLC, a Delaware limited liability company and indirect wholly-owned subsidiary of PCT LLC (the pledgor under an Equity Pledge and Security Agreement (as defined in the Indenture), pursuant to which the pledgor pledged certain interests to secure obligations of PCO under various Financing Documents (as defined in the Indenture) relating to the Revenue Bonds) and PCO and SOPA and the Trustee entered into a Limited Waiver and First Supplemental Indenture (the “Limited Waiver”), supplementing the Indenture and amending the Loan Agreement and the ARG, and pursuant to which the majority holders of the Series 2020A Bonds consented to the Limited Waiver, based on stated conditions, of a Specified Event of Default (as defined below) under the Indenture and the Loan Agreement.
Under the terms of the Loan Agreement, PCO was required to cause the Ironton Facility to be completed by December 1, 2022. The Ironton Facility was not completed by that date due to a variety of challenges resulting from,
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
among other things, the COVID-19 outbreak, the ongoing military conflict between Russia and Ukraine, and certain U.S. weather-related events (the “Specified Event of Default”).
Subject to the following conditions, the Specified Event of Default was waived in exchange for PCO’s agreement to meet certain milestones toward completing the Ironton Facility, to deposit additional equity aggregating approximately $87.3 million with the Trustee for various purposes and to make certain other representations and warranties; provided, however, that any failure to comply with the terms of the Limited Waiver would be an immediate Event of Default under the Indenture and Loan Agreement, which will be deemed to have occurred on January 2, 2023 with respect to any requirements to pay accrued and unpaid interest at the Default Rate (as defined in the Indenture).
PCO agreed to, among other things, achieve the following milestones (together, the “Milestones”): (i) closure by it or its direct or indirect parent entity of a financing transaction by March 31, 2023 that provides at least $150.0 million of working capital which may be used to support the Ironton Facility (which milestone was satisfied by the closing of the Revolving Credit Facility); (ii) mechanical completion of the Ironton Facility by June 30, 2023 (which milestone was satisfied on April 25, 2023); (iii) meet certain targeted production and performance targets during 2023; (iv) completion of the Ironton Facility by December 31, 2023; and (v) meet certain Ironton Facility pellet production targets by January 31, 2024 up to the Ironton Facility’s nameplate production capacity of 107 million pounds per year.
The additional approximately $87.3 million of equity deposited with the Trustee is comprised of: (i) a deposit of $50 million in an account controlled by the Trustee; (ii) a deposit of approximately $25 million in the Equity Account of the Project Fund (as such terms are used in the Indenture) to fund remaining construction costs; (iii) an aggregate deposit of approximately $12.3 million into the Capitalized Interest Accounts (as defined in the Indenture) for the Series 2020A Bonds, Series 2020B Bonds and Series 2020C Bonds to pay capitalized interest on the Revenue Bonds through June 30, 2024. The Limited Waiver also requires that the Liquidity Reserve of approximately $50 million remain in the Liquidity Reserve Escrow Fund (as defined in the Indenture) for a period beyond the completion date of the Ironton Facility until certain production requirements have been met, and only thereafter may the balance in that fund be reduced based on certain conditions to $25 million, which must remain therein as long as Series 2020A Bonds remain outstanding. The $50 million deposit described above, along with the $50 million remaining in the Liquidity Reserve Escrow Fund, may satisfy the minimum cash requirement of the ARG of $100 million. The Trustee also released $13.2 million from the Project Fund held under the Indenture for use as part of the remaining investment in 2023 to complete the Ironton Facility in accordance with the Limited Waiver.
As a result of the September Milestone Event of Default (as further described in Note 1 - Organization), on November 8, 2023, the Limited Waiver parties entered into the Second Limited Waiver. The principal terms of the Second Limited Waiver, include, but are not limited to, the following:
i.PCO will deposit an additional $50,000,000 (the “Trustee Account Deposit”) in the Trustee Account (as defined in the Limited Waiver), such that at least $100,000,000 (the “Aggregate Trustee Deposit”) shall be on deposit in the Trustee Account so long as any Revenue Bonds remain outstanding; provided, that if no Event of Default shall have occurred and be continuing, $50,000,000 of funds in the Trustee Account shall be released back to PCO upon satisfaction of the conditions set forth in Section 4.11(a) of the amended and restated Guaranty.
ii.subject to there being no default or event of default and compliance with the other terms of the Second Limited Waiver, once per quarter, PCO (and the Guarantor, if applicable) may request the release to PCO (or the Guarantor, as applicable) of any investment income or earnings with respect to amounts in the Trustee Account and the Liquidity Reserve Escrow Fund that have been invested pursuant to the terms of the Indenture or the Liquidity Reserve Escrow Agreement (as applicable).
iii.PCO shall have produced 4.45 million pounds of pellets from its feedstock for thirty consecutive days by December 31, 2023, which shall be evidenced by a certificate signed by an Authorized Representative of PCO and by the Construction Monitor certifying thereto and delivered to the Trustee;
iv.performance testing of the Ironton Facility shall be complete by no later than February 28, 2024, which shall be evidenced by a certificate signed by an Authorized Representative of PCO and by the Construction Monitor certifying thereto and delivered to the Trustee;
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
v.completion of the Project, including the acquisition, construction and equipping of the Ironton Facility, shall occur by no later than March 31, 2024, which shall be evidenced by a Certificate of Completion delivered to the Trustee;
vi.PCO shall have produced 8.90 million pounds of pellets from its feedstock for thirty consecutive days by April 30, 2024, which shall be evidenced by a certificate signed by an Authorized Representative of PCO and by the Construction Monitor certifying thereto and delivered to the Trustee; and PCO shall have fully-ramped production at the Ironton Facility to nameplate capacity of 107 million pounds per year produced from its feedstock by no later than April 30, 2024, which shall be evidenced by a certificate signed by an Authorized Representative of PCO and by the Construction Monitor certifying thereto and delivered to the Trustee; and
vii.the milestones referenced in (iii) – (vi) above (each, a “ Revised Milestone”), shall replace the corresponding Milestones in the Limited Waiver. If PCO fails to meet any of the Revised Milestones, no Event of Default shall have occurred until PCO has failed to meet such Revised Milestone on the date that is ninety days after such Revised Milestone date; provided, however, that during such ninety-day period, PCO will pay interest from the date of the Revised Milestone requirement until the date that the Revised Milestone is satisfied at the Default Rate, and notwithstanding anything to the contrary in the Indenture, the Loan Agreement, the Limited Waiver or the other Financing Documents or Bond Documents (each as defined in the Second Limited Waiver), PCO shall not have any access to any funds in the Trust Estate or otherwise held with the Trustee or a third-party (including, without limitation, funds in the Operating Revenue Escrow Fund and the Liquidity Reserve Escrow Fund (terms used as defined in the Second Limited Waiver)) pursuant to the Financing Documents until the date that such Milestone is satisfied.
Equipment Financing
CSC Leasing Co.
On May 8, 2023, the Company, through PureCycle PreP LLC, an indirect wholly-owned subsidiary of the Company, entered into a Master Lease Agreement (the “Master Lease Agreement”) with CSC Leasing Co. (“CSC”). Pursuant to the Master Lease Agreement, the Company and CSC agreed to enter into schedules that establish the specific terms and conditions of leasing certain equipment, machines, devices, features and any other items listed in each equipment lease schedule. The Master Lease Agreement commenced on the date set forth above and continues in effect until the later time that it is terminated, either by CSC at the end of any lease term, or by the Company upon three months written notice prior to the expiration of a lease term.
Also on May 8, 2023, the Company, also through PureCycle PreP LLC, an indirect wholly-owned subsidiary of the Company, entered into an Equipment Procurement Agreement (the “Equipment Agreement”) with CSC. Under the terms of the Equipment Agreement, CSC has agreed to finance, acquire and/or purchase certain equipment (the “Equipment”) from third-party vendors and/or manufacturers (each, a “Vendor”), so that CSC may lease the Equipment to the Company pursuant to the terms and conditions of the Master Lease Agreement. Prior to entering into formal lease schedules under the Master Lease Agreement, the Company will lease from CSC certain Equipment pursuant to the terms of the Equipment Agreement.
In connection with the above, CSC has funded $19.8 million for purposes of procuring equipment from a Vendor, which had previously been ordered by the Company prior to entering into these agreements with CSC. CSC will lease this equipment back to the Company under a 36 month lease, which will commence when 1) the Company accepts delivery of the equipment at its operating location and 2) all final bills from Vendor are paid. The Company has determined that it did not relinquish control of the assets to the buyer-lessor under these arrangements. Therefore, the Company has accounted for this transaction as a failed sale-leaseback transaction whereby it has continued recording these assets in the condensed consolidated balance sheet and also recorded a financing obligation for the consideration paid by the buyer-lessor. The Company currently expects the lease term to commence in late second quarter of 2024, and the repayment schedule below assumes payments under the 36 month term commence on June 1, 2024.
The Company is also required to make monthly payments under the agreements during the period between funding of the construction obligation and delivery of the equipment, which began in June 2023 and are equal to a monthly lease rate factor of approximately 3.1% of the outstanding amount funded by CSC (the “Lease Rate Factor”). The
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Company has determined that these payments represent a cost of borrowing under the financing arrangement and has recorded the payments as interest expense in the condensed consolidated statements of comprehensive income (loss). The Company incurred $1.9 million and $2.7 million of interest related to these obligations for the three and nine months ended September 30, 2023. The Lease Rate Factor is indexed to the WSJ Prime Rate as published by the Wall Street Journal and may be increased for every five basis point change in the index prior to final commencement of the 36 month lease term. Upon commencement of the 36 month lease term, the payments will be characterized as repayment of debt, and the expected coupon rate for the 36 month term is 7.25% based on the WSJ Prime Rate published as of September 30, 2023.
The Master Lease Agreement contains representations, covenants and events of default that are customary for financing transactions of this nature. Events of default in the Master Lease Agreement include, among others: (a) non-payment of principal, interest, fees or other amounts; (b) default of specific covenants; (c) breach of representations and warranties; (d) discontinuation of authorized electronic payments without CSC’s consent; (e) failure to furnish proof of insurance; (f) bankruptcy and insolvency proceedings; and (g) any unauthorized conveyance or transfer of the Equipment to a third party. Upon the occurrence of an event of default, CSC may accelerate all unpaid rents and exercise all rights and remedies available to it under the Master Lease Agreement and Equipment Agreement. Amounts due under the lease are guaranteed by PCT.
Other Equipment Financing
The Company has executed other equipment sale leasebacks which qualify as financing arrangements, with a total of $2.1 million outstanding as of September 30, 2023.
Sylebra Credit Facility
On March 15, 2023, PCT entered into a $150 million Revolving Credit Facility pursuant to a Credit Agreement (the “Revolving Credit Agreement”) dated as of March 15, 2023, with PureCycle Technologies Holdings Corp. and PureCycle Technologies, LLC (the “Guarantors”), Sylebra Capital Partners Master Fund, LTD, Sylebra Capital Parc Master Fund, and Sylebra Capital Menlo Master Fund (collectively, the “Lenders”), and Madison Pacific Trust Limited (the “Administrative Agent”), which matures on March 31, 2025 (as further described in the Second Amendment (as defined below)). The Lenders and their affiliates are greater than 5% beneficial owners of PCT.
Borrowings under the Revolving Credit Agreement may be used for working capital, capital expenditures and other general corporate purposes and satisfies the financing obligation imposed upon PCT by the Limited Waiver.
Amounts outstanding under the Revolving Credit Agreement bear interest at a variable annual rate equal to Term SOFR (as defined in the Revolving Credit Agreement) in effect for such period plus an applicable margin. The applicable margin is equal to (i) 5.00% from the Closing Date through June 30, 2023, (ii) 10.00% from July 1, 2023 through September 30, 2023, (iii) 12.50% from October 1, 2023 through December 31, 2023, (iv) 15.00% from January 1, 2024 through March 31, 2024, and (v) 17.50% thereafter. PCT is also required to pay (i) an up-front fee equal to 0.75% times $150 million—the total aggregate commitment for the Revolving Credit Facility—to the Lenders, payable at closing and (ii) a commitment fee equal to 0.25% per annum based on the actual daily unused amount of the Revolving Credit Facility, payable quarterly. Subject to timely prior written notice and payment of breakage fees, if any, PCT may at any time and from time to time (i) terminate all or any portion of the commitments under the Revolving Credit Agreement and/or (ii) prepay all or any portion of any outstanding borrowings.
The Revolving Credit Agreement contains representations, covenants and events of default that are customary for financing transactions of this nature. Events of default in the Revolving Credit Agreement include, among others: (a) non-payment of principal, interest, fees or other amounts; (b) default of specific covenants; (c) breach of representations and warranties; (d) cross-defaults to other indebtedness in an amount greater than $1 million, subject to certain exceptions; (e) bankruptcy and insolvency proceedings; (f) inability to pay debts or attachment; (g) judgments; and (h) change of control. Upon the occurrence of an event of default, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders (as defined in the Revolving Credit Agreement) terminate the loan commitments, accelerate all loans and exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Revolving Credit Agreement and the other loan documents.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Amounts outstanding under the Revolving Credit Agreement are guaranteed by the Guarantors, and are secured by a security interest in substantially all of the assets of PCT. Any majority-owned direct or indirect subsidiaries of PCT formed after the closing date of the Revolving Credit Facility will also be required to guaranty the obligations under the Revolving Credit Agreement and grant security interests in substantially all of their respective assets.
On May 8, 2023, the Company entered into the First Amendment to Credit Agreement, by and among the Company, as borrower, PureCycle Technologies, LLC and PureCycle Technologies Holdings Corp., as Guarantors, the lenders party thereto, and Madison Pacific Trust Limited, as administrative agent and as security agent (the “Sylebra Amendment”) in connection with the Company’s $150 million Revolving Credit Facility governed by the Revolving Credit Agreement. The Sylebra Amendment, among other things: (i) permits the Company’s entry into the Term Loan Facility (as defined below), (ii) provides for a new basket under the Revolving Credit Agreement’s indebtedness negative covenant allowing for offerings of unsecured convertible promissory notes of up to $200,000,000, (iii) provides for new baskets under the Revolving Credit Agreement’s indebtedness and lien negative covenants of up to $90,000,000 in additional equipment financings and (iv) exempts the proceeds of any such convertible notes offerings from the requirement for mandatory prepayments under the Revolving Credit Agreement.
On August 4, 2023, the Company entered into the Second Amendment to Credit Agreement, by and among the Company, as borrower, PureCycle Technologies, LLC and PureCycle Technologies Holdings Corp., as Guarantors, the lenders party thereto, and Madison Pacific Trust Limited, as administrative agent and as security agent (the “Second Amendment”), in connection with the Company’s $150 million Revolving Credit Facility governed by the Revolving Credit Agreement, to extend the maturity date of the Revolving Credit Facility to March 31, 2025.
On August 21, 2023, the Company further amended the Revolving Credit Agreement to (i) increase the amount available to the Company under the indebtedness covenant basket for offerings of unsecured convertible notes from $200,000,000 to $250,000,000 and (ii) make certain changes to the restricted payments covenant and the events of default section in order to permit the Notes (as defined below).
There were no funds drawn on the Revolving Credit Facility as of September 30, 2023. The up-front commitment fee and other costs of $1.3 million have been recorded in prepaid expenses and other current assets and will be amortized over the term of the contract.
The Pure Plastic Term Loan Facility
On May 8, 2023, the Company entered into a $40 million Term Loan Facility pursuant to the Term Loan Credit Agreement dated as of May 8, 2023, among the Company, the Guarantors and Pure Plastic LLC (as Lender, Administrative Agent, and Security Agent), which matures on December 31, 2025 (the “Term Loan Facility”). Affiliates of the Lender are greater than 5% beneficial owners of the Company. Balances related to the Term Loan Credit Agreement are recorded within related party note payable in the condensed consolidated balance sheets and, in certain instances, the Term Loan Credit Agreement is referred to as the “Related party note payable.”
Borrowings under the Term Loan Credit Agreement may be used to repay indebtedness for borrowed money of the Company, to pay fees and expenses associated with the Term Loan Credit Agreement and the other loan documents and for general corporate purposes not in contravention of any law or of any loan document.
The Term Loan Facility is structured as a single-draw, delayed draw term loan. The Lender funded the term loan on May 17, 2023 (the “Funding Date”). Amounts outstanding under the Term Loan Credit Agreement will bear interest at a variable annual rate equal to Term SOFR (as defined in the Term Loan Credit Agreement) in effect for such period plus an applicable margin. The applicable margin is equal to 7.5%, and the interest rate for the outstanding term loan was 12.9% as of September 30, 2023. The Company is also required to pay, on the Funding Date, (i) a closing fee to the Lenders, equal to 2.00% times the aggregate principal amount of the term loans funded by the Lenders on the Funding Date, (ii) a commitment fee to the Lenders equal to 1.00% times the aggregate principal amount of each Lender’s commitments on the Funding Date, (iii) a syndication fee to the Administrative Agent equal to 0.50% times the aggregate commitments of the Lenders on the Funding Date and (iv) a monitoring fee equal to $200,000 to the Administrative Agent for the account of the Administrative Agent and the Security Agent on the Funding Date and each anniversary of the Funding Date until maturity of the term loan. Additionally, the term loan will be issued with a 5.00% original issue discount. Subject to timely prior written notice, payment of breakage fees,
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
if any, and payment of a prepayment premium equal to (i) 12% if such prepayment occurs during the first year following the closing date or (ii) 8% thereafter, the Company may at any time and from time to time voluntarily prepay all or any portion of any outstanding borrowings. The Company incurred $1.3 and $2.0 million of interest cost during the three and nine months ended September 30, 2023. The interest due to date of $1.7 million was paid entirely in kind, which increased the principal amount of the Term Loan Facility by this amount (the “PIK Interest”). The Company has the contractual right to pay all interest payments in kind and may make this election for all interest payments for the duration of the Term Loan Facility. The repayment schedule presented below does not contemplate future PIK Interest.
The Term Loan Credit Agreement contains representations, covenants and events of default that are customary for financing transactions of this nature. Events of default in the Term Loan Credit Agreement include, among others: (a) non-payment of principal, interest, fees or other amounts; (b) default of specific covenants; (c) breach of representations and warranties; (d) cross-defaults to other indebtedness in an amount greater than $1 million, subject to certain exceptions; (e) bankruptcy and insolvency proceedings; (f) inability to pay debts or attachment; (g) judgments; and (h) change of control. Upon the occurrence of an event of default, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders (as defined in the Term Loan Credit Agreement) accelerate all loans and exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Term Loan Credit Agreement and the other loan documents.
Amounts outstanding under the Term Loan Credit Agreement are guaranteed by the Guarantors, and are secured by a security interest in substantially all of the assets of the Company. Subject to certain limited exceptions, any majority-owned direct or indirect subsidiaries of the Company formed after the closing date of the Term Loan Facility will also be required to guaranty the obligations under the Term Loan Credit Agreement and grant security interests in substantially all of their respective assets.
On August 21, 2023, the Company amended the Term Loan Credit Agreement to (i) increase the amount available to the Company under the indebtedness covenant basket for offerings of unsecured convertible notes from $200,000,000 to $250,000,000 and (ii) make certain changes to the restricted payments covenant and the events of default section in order to permit the Notes.
Green Convertible Notes
On August 21, 2023, the Company priced its private offering of $215.0 million in aggregate principal amount of 7.25% Green Convertible Senior Notes due 2030 (the “Initial Notes”). On August 22, 2023, the initial purchaser in such offering exercised its option to purchase an additional $35.0 million in aggregate principal amount of the 7.25% Green Convertible Senior Notes due 2030 (together with the “Initial Notes”, the “Notes”), bringing the total aggregate principal amount of the Notes to $250.0 million.
On August 24, 2023, the Company completed the private offering of the Notes. Each $1,000 principal amount at maturity of the Notes was issued at a price of $900. An amount equal to the difference between the issue price and the principal amount at maturity will accrete from the original issue date through August 15, 2027. The Notes are senior unsecured obligations of the Company. Entities affiliated with Sylebra Capital Management purchased $50.0 million aggregate principal amount at maturity of Notes.
The net proceeds from this offering were approximately $218.50 million, after deducting the initial purchaser’s discounts and fees paid to our financial advisor. The Company intends to allocate an amount equal to the net proceeds from this offering to the financing and refinancing of recently completed and future Eligible Green Projects (as defined below) in the United States. In particular, the Company intends to allocate the net proceeds from this offering to make payments on certain long-lead items and fund initial outside battery limits engineering design work, both associated with a multi-line purification facility to be built in Augusta, Georgia. Pending such allocation, the Company intends to use the remaining net proceeds for general corporate purposes.
“Eligible Green Projects” means: (i) investments in acquisitions of buildings; (ii) building developments or redevelopments; (iii) renovations in existing buildings; and (iv) tenant improvement projects, in each case, that have received, or are expected to receive, in the three years prior to the issuance of the Notes or during the term of the Notes, a Leadership in Energy and Environmental Design (LEED) Silver, Gold or Platinum certification (or environmentally equivalent successor standards).
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
In connection with the issuance of the Notes, the Company entered into an Indenture, dated August 24, 2023 (the “Indenture”), with U.S. Bank Trust Company, National Association, as trustee. The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The events of default, as set forth in the Indenture and subject in certain cases to customary grace and cure periods, include customary events including a default in the payment of principal or interest, failure to comply with the obligation to deliver amounts due upon conversion, failure to give certain notices, failure to comply with the obligations in respect of certain merger transactions, defaults under certain other indebtedness and certain events of bankruptcy and insolvency.
The Notes will mature on August 15, 2030 (the “Maturity Date”), unless earlier repurchased, redeemed or converted. The Notes will bear interest at a rate of 7.25% per annum on the principal amount at maturity from August 24, 2023, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2024.
Holders of the Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election. The conversion rate will initially be 67.4764 shares of common stock per $1,000 principal amount at maturity of notes (equivalent to an initial conversion price of approximately $14.82 per share of common stock), which represents a conversion premium of approximately 50% to the $9.88 per share closing price of the Company’s common stock on the Nasdaq Capital Market on August 21, 2023. The conversion rate will be subject to adjustment upon the occurrence of certain events. In addition, following certain corporate events described in the Indenture that occur prior to August 15, 2027, or upon the issuance of a notice of redemption (as described below) prior to August 15, 2027 for an optional redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event or elects to convert its notes called (or deemed called) for optional redemption during the related redemption period.
Holders of the Notes have the right to require the Company to repurchase for cash all or any portion of their Notes on August 15, 2027 at a repurchase price equal to 100% of the principal amount at maturity of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, August 15, 2027. In addition, if the Company undergoes a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase their Notes at a cash repurchase price equal to 100% of the accreted principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The Company may not redeem the Notes prior to August 20, 2025. The Company may redeem for cash all or any portion of the Notes (subject to certain exceptions and restrictions specified in the Indenture), at its option, on or after August 20, 2025 and on or before the 40th scheduled trading day immediately before the Maturity Date, at a cash redemption price equal to 100% of the accreted principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption to the holders of the Notes. No sinking fund is provided for the Notes.
The following provides a summary of the interest expense of PCT’s convertible debt instruments (in thousands):
| | | | | | | | | | | | | | | | | |
| Three months ended September 30 | | Nine months ended September 30 |
| 2023 | 2022 | | 2023 | 2022 |
Contractual interest expense | $ | 1,863 | | $ | — | | | $ | 1,863 | | $ | — | |
Amortization of deferred financing costs | $ | 643 | | $ | — | | | $ | 643 | | $ | — | |
Effective interest rate | 11.2 | % | — | % | | 11.2 | % | — | % |
| | | | | |
The following provides a summary of the convertible notes (in thousands):
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
| | | | | | | | | | | | |
| | As of |
| | September 30 2023 | | September 30 2022 |
Unamortized deferred issuance costs | | $ | 30,855 | | | $ | — | |
Net carrying amount | | 219,145 | | | — | |
Fair value | | $ | 177,750 | | | $ | — | |
Fair value level | | Level 3 | | — | |
Principal repayments due on Long-term debt and Related party note payable over the next five years are as follows (in thousands):
| | | | | | | | | | | | | | |
Years ending December 31, | | Long-term debt | | Related party note payable |
2023 (October through December) | | $ | 402 | | | $ | — | |
2024 | | 12,249 | | | — | |
2025 | | 23,106 | | | 41,745 | |
2026 | | 14,424 | | | — | |
2027 | | 28,110 | | | — | |
2028 | | 257,710 | | | — | |
Thereafter | | 185,460 | | | — | |
| | 521,461 | | | 41,745 | |
Less: Original issue discount and debt issuance costs classified as a reduction to long-term debt | | (46,079) | | | (3,716) | |
Less: Current Portion | | (7,065) | | | — | |
Total | | $ | 468,317 | | | $ | 38,029 | |
NOTE 4 - STOCKHOLDERS’ EQUITY
Common Stock
Holders of PCT common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. The holders do not have cumulative voting rights in the election of directors. Upon the Company’s liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences, if any, the holders of the Company’s common stock will be entitled to receive pro rata the Company’s remaining assets available for distribution. Holders of the Company’s common stock do not have preemptive, subscription, redemption or conversion rights. All shares of the Company’s common stock are fully paid and non-assessable. The Company is authorized to issue 450.0 million shares of common stock with a par value of $0.001. As of September 30, 2023, and December 31, 2022, 164.06 million and 163.55 million shares are issued and outstanding, respectively.
Preferred Stock
As of September 30, 2023, the Company is authorized to issue 25.0 million shares of preferred stock with a par value of $0.001, of which no shares are issued and outstanding.
NOTE 5 - EQUITY-BASED COMPENSATION
2021 Equity Incentive Plan
On March 17, 2021, our stockholders approved the PureCycle Technologies, Inc. 2021 Equity and Incentive Compensation Plan (the “Plan”).
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
The Plan provides for the grant of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance shares, performance units, dividend equivalents, and certain other awards. In general, the amount of shares issuable under the Plan will be automatically increased on the first day of each fiscal year, beginning in 2022 and ending in 2031, by an amount equal to the lesser of (a) 3% of the shares of the Company’s common stock outstanding on the last day of the immediately preceding fiscal year and (b) such smaller number of shares as determined by the Board of Directors (the “Board”) of the Company.
As of September 30, 2023, approximately 17.0 million shares of common stock are currently authorized for issuance under the Plan, of which approximately 8.9 million shares remain available for issuance under the Plan (assuming maximum performance with respect to the applicable performance goals applicable to the issued Plan awards).
Restricted Stock Agreements
RSUs issued pursuant to the Plan are time-based and vest over the period defined in each individual grant agreement or upon a change of control event as defined in the Plan. The Company recognizes compensation expense for the shares equal to the fair value of the equity-based compensation awards and is recognized on a straight-line basis over the vesting period of such awards. The fair value of the awards is equal to the fair value of the Company’s common stock at the date of grant. The Company has the option to repurchase all vested shares upon a stockholder’s termination of employment or service with the Company.
A summary of restricted stock activity for the nine months ended September 30, 2023 and 2022 is as follows (in thousands except per share data):
| | | | | | | | | | | | | | | | | |
| Number of RSUs | | Weighted average grant date fair value | | Weighted average remaining recognition period |
| | | | | |
Non-vested at December 31, 2021 | 2,671 | | $ | 14.33 | | | 3.4 |
Granted | 1,395 | | 7.61 | | |
Vested | (872) | | 6.47 | | |
Forfeited | (441) | | 9.78 | | |
Non-vested at September 30, 2022 | 2,753 | | | $ | 11.52 | | | 2.9 |
| | | | | | | | | | | | | | | | | |
| Number of RSUs | | Weighted average grant date fair value | | Weighted average remaining recognition period |
| | | | | |
Non-vested at December 31, 2022 | 2,760 | | $ | 11.92 | | | 2.7 |
Granted | 1,254 | | 6.22 | | |
Vested | (716) | | 11.69 | | |
Forfeited | (114) | | 10.24 | | |
Non-vested at September 30, 2023 | 3,184 | | | $ | 9.75 | | | 2.4 |
Equity-based compensation cost is recorded within the selling, general and administrative expenses in the condensed consolidated statements of comprehensive income (loss), and totaled approximately $2.8 million and $8.1 million for the three and nine months ended September 30, 2023, respectively, and $2.4 million and $8.7 million for the three and nine months ended September 30, 2022, respectively.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Stock Options
The stock options issued pursuant to the Plan are time-based and vest over the period defined in each individual grant agreement or upon a change of control event as defined in the Plan.
The Company recognizes compensation expense for the shares equal to the fair value of the equity-based compensation awards and is recognized on a straight-line basis over the vesting period of such awards. The fair value of the stock is estimated on the date of grant using the Black-Scholes option-pricing model using the following assumptions:
| | | | | | | | | | | |
| September 30, 2023 | | September 30, 2022 |
Expected annual dividend yield | — | % | | — | % |
Expected volatility | 77.30 | % | | — | % |
Risk-free rate of return | 3.54 | % | | — | % |
Expected option term (years) | 6.50 | | — | |
The expected term of the shares granted is determined based on the period of time the shares are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected volatility was based on the Company’s capital structure and volatility of similar entities referred to as guideline companies. In determining similar entities, the Company considered industry, stage of life cycle, size and financial leverage. The dividend yield on the Company’s shares is assumed to be zero as the Company has not historically paid dividends. The fair value of the underlying Company shares was determined using the Company’s closing stock price on the grant date.
A summary of stock option activity for the nine months ended September 30, 2023 and 2022 is as follows (in thousands except per share data):
| | | | | | | | | | | | | | | | | |
| Number of Options | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) |
Balance, December 31, 2021 | 613 | | $ | 28.90 | | | 6.2 |
Granted | — | | — | | |
Exercised | — | | — | | |
Forfeited | — | | — | | |
Balance, September 30, 2022 | 613 | | $ | 28.90 | | | 4.3 |
| | | | | | | | | | | | | | | | | |
| Number of Options | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) |
Balance, December 31, 2022 | 613 | | $ | 28.90 | | | 4.0 |
Granted | 459 | | 5.72 | | 10.0 |
Exercised | — | | — | | |
Forfeited | (5) | | 5.72 | | |
Balance, September 30, 2023 | 1,067 | | $ | 19.03 | | | 5.9 |
Exercisable | 613 | | | | |
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Equity-based compensation cost is recorded within the selling, general and administrative expenses within the condensed consolidated statements of comprehensive income (loss) and was not material for the three and nine months ended September 30, 2023 and 2022. The weighted average grant-date fair values of options granted during the nine months ended September 30, 2023 and 2022 were $4.07 and $0, respectively. There were no stock options exercised during 2023 or 2022.
Performance-Based Restricted Stock Agreements
The shares issued pursuant to the Performance-Based Restricted Stock Agreements vest depending on if the performance obligations are met. In general, the performance-based stock units (“Performance PSUs”) will be earned based on achievement of pre-established financial and operational performance objectives and will vest on the date the attainment of such performance objectives as determined by the Compensation Committee (the “Committee”) of the Board, subject to the participant’s continued employment with the Company. The Company has also issued performance-based stock units that vest if the market price of the Company’s common stock exceeds a defined target during the performance period (“Market PSUs”, together with the Performance PSUs, the “PSUs”).
The Company issued 0.4 million and 1.0 million PSUs for the nine months ended September 30, 2023, and 2022, respectively. As of September 30, 2023, the performance-based provision has not been achieved for any of the outstanding performance-based awards.
The Company recognizes compensation expense for the Performance PSUs equal to the fair value of the equity-based compensation awards and is recognized on a straight-line basis over the vesting period of such awards as the Company has concluded the performance condition is probable to be met. The fair value of the awards is equal to the fair value of the Company’s common stock at the date of grant.
A summary of the PSU activity for the nine months ended September 30, 2023 and 2022 is as follows (in thousands except per share data):
| | | | | | | | | | | | | | | | | |
| Number of PSUs | | Weighted average grant date fair value | | Weighted average remaining recognition period |
Balance, December 31, 2021 | 424 | | $ | 18.65 | | | 2.0 |
Granted | 1,020 | | 7.53 | | — |
Vested | — | | — | | — |
Forfeited | (382) | | 10.59 | | — |
Balance, September 30, 2022 | 1,062 | | $ | 10.86 | | | 1.9 |
| | | | | | | | | | | | | | | | | |
| Number of PSUs | | Weighted average grant date fair value | | Weighted average remaining recognition period |
Balance, December 31, 2022 | 1,060 | | $ | 10.87 | | | 1.7 |
Granted | 416 | | 6.08 | | — |
Vested | — | | — | | — |
Forfeited | (11) | | 6.84 | | — |
Balance, September 30, 2023 | 1,465 | | $ | 9.53 | | | 1.5 |
Equity-based compensation cost is recorded within the selling, general and administrative expenses within the consolidated statements of comprehensive income (loss), and was not material for the three and nine months ended September 30, 2023 and 2022.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
NOTE 6 - WARRANTS
RTI Warrants
RTI Global (“RTI”) holds warrants to purchase 971 thousand shares of PCT common stock. RTI can exercise these warrants as of March 17, 2022. The warrants expire on December 31, 2024. The Company determined the warrants are liability classified under ASC 480. Accordingly, the warrants were held at their initial fair value and will be remeasured at fair value at each subsequent reporting date with changes in the fair value presented in the statements of comprehensive income (loss).
A summary of the RTI warrant activity for the nine months ended September 30, 2023 and 2022 is as follows (in thousands, except per share data):
| | | | | | | | | | | | | | | | | | | | | | | |
| Number of warrants | | Weighted average exercise price | | Weighted average grant date fair value | | Weighted average remaining contractual term (years) |
Outstanding at December 31, 2021 | 971 | | | $ | 5.56 | | | $ | 0.03 | | | 3.0 |
Granted | — | | | — | | | — | | | — | |
Exercised | — | | | — | | | — | | | — | |
Outstanding at September 30, 2022 | 971 | | | $ | 5.56 | | | $ | 0.03 | | | 2.3 |
Exercisable | 971 | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Number of warrants | | Weighted average exercise price | | Weighted average grant date fair value | | Weighted average remaining contractual term (years) |
Outstanding at December 31, 2022 | 971 | | | $ | 5.56 | | | $ | 0.03 | | | 2.0 |
Granted | — | | | — | | | — | | | — | |
Exercised | — | | | — | | | — | | | — | |
Outstanding at September 30, 2023 | 971 | | | $ | 5.56 | | | $ | 0.03 | | | 1.3 |
Exercisable | 971 | | | | | | | |
The Company recognized $4.0 million and $1.5 million of benefit for the three and nine months ended September 30, 2023, respectively, and $1.2 million of expense and $0.6 million of benefit for the three and nine months ended September 30, 2022, respectively. Refer to Note 12 – Fair Value of Financial Instruments for further information.
Public Warrants and Private Warrants
The Company has outstanding public and private warrants which entitle each holder to exercise its warrants only for a whole number of shares of Common Stock. Each whole warrant entitles the registered holder to purchase one whole share of the Company’s Common Stock at a price of $11.50 per share at the later of the closing of the Business Combination or one year after ROCH’s initial public offering, provided that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. The warrants will expire five years after March 17, 2021, or earlier upon redemption or liquidation. The private warrants are identical to the public warrants, except that the private warrants and the common stock issuable upon exercise of the private warrants were not transferable, assignable or salable until after March 17, 2021, subject to certain limited exceptions. Additionally, the private warrants are non-redeemable so long as they are held by the initial holder or any of its permitted transferees. If the private warrants are held by someone other than the initial holder or its permitted transferees, the private warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
The Company may redeem the outstanding warrants in whole, but not in part, at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If the Company calls the warrants for redemption, management will have the option to require all holders that wish to exercise the warrants to do so on a cashless basis. In no event will the Company be required to net cash settle the warrant exercise. The public warrants are accounted for as equity classified warrants as they were determined to be indexed to the Company’s stock and meet the requirements for equity classification.
The Company has classified the private warrants as a warrant liability as there is a provision within the warrant agreement that allows for private warrants to be exercised via a cashless exercise while held by CR Financial Holdings, Inc. (the “Sponsor”) and affiliates of the Sponsor, but would not be exercisable at any time on a cashless basis if transferred and held by another investor. Therefore, the Company will classify the private warrants as a liability pursuant to ASC 815 until the private warrants are transferred from the initial purchasers or any of their permitted transferees.
There were approximately 5.7 million public warrants and 0.2 million private placement warrants outstanding at September 30, 2023 and 2022. The Company recognized $0.7 million and $0.3 million of benefit related to the private warrants for the three and nine months ended September 30, 2023, respectively, and $0.2 million and $0 of expense for the three and nine months ended September 30, 2022. Refer to Note 12 - Fair Value of Financial Instruments for further information.
Series A Warrants
Upon the closing of the 2022 PIPE Offering, the Company issued approximately 17.9 million Series A Warrants to the 2022 PIPE Investors to purchase shares of the Company’s common stock. Each whole warrant entitles the registered holder to purchase one whole share of the Company’s Common Stock at a price of $11.50 per share any time after September 17, 2022 (the “Initial Exercise Date”), provided that the Company has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of Common Stock. The warrants will expire on March 17, 2026.
The Company may redeem the outstanding Series A Warrants in whole, but not in part, at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, if and only if the last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period commencing after the Series A Warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders. If the Company calls the Series A Warrants for redemption, management will have the option to require all holders that wish to exercise the warrants to do so on a cashless basis. In no event will the Company be required to net cash settle the warrant exercise.
The agreements governing the Series A Warrants (the “Series A Warrant Agreements”) provide for a Black-Scholes value calculation (“Black-Scholes Value”) in the event of certain transactions (“Fundamental Transactions”), which includes a floor on volatility utilized in the value calculation at 100% or greater. The Company has determined this provision introduces leverage to the holders of the Series A Warrants that could result in a value that would be greater than the settlement amount of a fixed-for-fixed option on the Company’s own equity shares. Therefore, the Company will classify the Series A Warrants as a liability pursuant to ASC 815.
As of September 30, 2023, there were approximately 17.9 million Series A Warrants outstanding. The Company recognized $44.1 million and $15.9 million of benefit related to the Series A Warrants for the three and nine months ended September 30, 2023, respectively, and $13.4 million and $16.8 million of expense for the three and nine months ended September 30, 2022, respectively. Refer to Note 12 – Fair Value of Financial Instruments for further information.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
NOTE 7 – RELATED PARTY TRANSACTIONS
Sylebra Credit Facility
On March 15, 2023, PCT entered into the Revolving Credit Facility pursuant to the Revolving Credit Agreement with the Guarantors, Lenders, and the Administrative Agent, which matures on March 31, 2025. The Revolving Credit Facility was amended on May 8, 2023, August 4, 2023 and August 21, 2023. The Lenders and their affiliates are greater than 5% beneficial owners of PCT. Refer to Note 3 - Notes Payable and Debt Instruments for further information.
The Pure Plastic Term Loan Facility
On May 8, 2023, the Company entered into a $40.0 million Term Loan Facility pursuant to the Term Loan Credit Agreement dated as of May 8, 2023, among the Guarantors and Pure Plastic LLC (as Lender, Administrative Agent, and Security Agent), which matures on December 31, 2025. The Term Loan Credit Agreement was amended on August 21, 2023. Affiliates of the Lender are greater than 5% beneficial owners of the Company. Balances related to the Term Loan Credit Agreement are recorded within related party note payable in the condensed consolidated balance sheets and, in certain instances, the Term Loan Credit Agreement is referred to as the “Related party note payable.” Refer to Note 3 - Notes Payable and Debt Instruments for further information.
Green Convertible Notes
On August 24, 2023, the Company completed the private offering of the Notes. Entities affiliated with a greater than 5% beneficial owner of the Company purchased $50.0 million aggregate principal amount at maturity of the Notes.
NOTE 8 – NET INCOME (LOSS) PER SHARE
The Company follows the two-class method when computing net loss per common share when shares are issued that meet the definition of participating securities. The two-class method requires income available to common shareholders for the period to be allocated between common and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The two-class method also requires losses for the period to be allocated between common and participating securities based on their respective rights if the participating security contractually participates in losses. As holders of participating securities do not have a contractual obligation to fund losses, undistributed net losses are not allocated to nonvested restricted stock for purposes of the loss per share calculation.
Presented in the table below is a reconciliation of the numerator and denominator for the basic earnings per share (“EPS”) calculations for the three and nine months ended September 30, 2023 and 2022 (in thousands):
| | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, |
| 2023 | 2022 | | 2023 | 2022 |
| | | | | |
Net income (loss) attributable to PureCycle Technologies | $ | 4,886 | | $ | (34,948) | | | $ | (77,532) | | $ | (75,384) | |
Less income attributable to participating warrants | (480) | | — | | | — | | — | |
Net income (loss) attributable to common shareholders | $ | 4,406 | | $ | (34,948) | | | $ | (77,532) | | $ | (75,384) | |
| | | | | |
Weighted average common shares outstanding, basic | 164,018 | | 163,490 | | | 163,783 | | 153,513 | |
Net loss per share attributable to common stockholder, basic | $ | 0.03 | | $ | (0.21) | | | $ | (0.47) | | $ | (0.49) | |
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Presented in the table below is a reconciliation of the numerator and denominator for the diluted EPS calculations for the three and nine months ended September 30, 2023 and 2022 (in thousands):
| | | | | | | | | | | | | | | | | |
| Three months ended September 30, | | Nine months ended September 30, |
| 2023 | 2022 | | 2023 | 2022 |
Numerator: | | | | | |
Net income (loss) attributable to PureCycle Technologies | $ | 4,886 | | $ | (34,948) | | | $ | (77,532) | | $ | (75,384) | |
Less change in fair value of RTI Warrants | (4,049) | | — | | | (1,485) | | (553) | |
| | | | | |
Less income attributable to participating warrants | (81) | | — | | | — | | — | |
Net income (loss) attributable to common shareholders | $ | 756 | | $ | (34,948) | | | $ | (79,017) | | $ | (75,937) | |
Denominator: | | | | | |
Weighted average common shares outstanding, basic | 164,018 | | 163,490 | | | 163,783 | | 153,513 | |
| | | | | |
Add common equivalent shares from warrants | 395 | | — | | | 197 | | 186 | |
Add common equivalent shares from equity awards | 1,135 | | — | | | — | | — | |
Weighted average common shares outstanding, diluted | 165,548 | | 163,490 | | | 163,980 | | 153,699 | |
| | | | | |
Net loss per share attributable to common stockholder, diluted | $ | 0.00 | | $ | (0.21) | | | $ | (0.48) | | $ | (0.49) | |
Certain outstanding common share equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented as including them would have been anti-dilutive. For the three months ended September 30, 2023 and 2022, the Company had outstanding instruments of approximately 23.8 million and 24.7 million warrants, 0.6 million and 0.6 million stock options, 0.7 million and 2.6 million non-vested restricted stock units, 1.5 million and 1.1 million non-vested performance stock units, 4.0 million and 4.0 million contingently-issuable shares related to the Earnout, and 16.9 million and 0 shares issuable upon conversion of the Green Convertible Notes (as described further in Note 3 – Notes Payable and Debt Instruments) which could be dilutive to the calculation in the future, respectively. For the nine months ended September 30, 2023 and 2022, the Company had outstanding instruments of approximately 23.8 million and 23.8 million warrants, 1.1 million and 0.6 million stock options, 3.1 million and 2.6 million non-vested restricted stock units, 1.5 million and 1.1 million non-vested performance stock units, 4.0 million and 4.0 million contingently-issuable shares related to the Earnout, and 16.9 million and 0 shares issuable upon conversion of the Green Convertible Notes which could be dilutive to the calculation in the future, respectively.
NOTE 9 – PROPERTY, PLANT AND EQUIPMENT
Presented in the table below are the major classes of property, plant and equipment by category as of the below dates:
| | | | | | | | | | | | | | | | | |
| As of September 30, 2023 |
(in thousands) | Cost | | Accumulated Depreciation | | Net Book Value |
Building | $ | 81,526 | | | $ | 1,893 | | | $ | 79,633 | |
Machinery and equipment | 329,656 | | | 19,836 | | | 309,820 | |
Leasehold Improvements | 2,957 | | | 1,284 | | | 1,673 | |
Fixtures and Furnishings | 679 | | | 151 | | | 528 | |
Land improvements | 150 | | | 30 | | | 120 | |
Land | 1,150 | | | — | | | 1,150 | |
Construction in process | 233,001 | | | — | | | 233,001 | |
Total property, plant and equipment | $ | 649,119 | | 649,119 | | $ | 23,194 | | | $ | 625,925 | |
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
| | | | | | | | | | | | | | | | | |
| As of December 31, 2022 |
(in thousands) | Cost | | Accumulated Depreciation | | Net Book Value |
Building | $ | 12,534 | | | $ | 1,016 | | | $ | 11,518 | |
Machinery and equipment | 23,728 | | | 6,674 | | | 17,054 | |
Leasehold Improvements | 2,957 | | | 803 | | | 2,154 | |
Fixtures and Furnishings | 529 | | | 83 | | | 446 | |
Land improvements | 150 | | | 22 | | | 128 | |
Land | 1,150 | | | — | | | 1,150 | |
Construction in process | 473,269 | | | — | | | 473,269 | |
Total property, plant and equipment | $ | 514,317 | | | $ | 8,598 | | | $ | 505,719 | |
Depreciation expense is recorded within operating costs in the condensed consolidated statements of comprehensive income (loss) and amounted to $9.3 million and $14.6 million for the three and nine months ended September 30, 2023, respectively, and $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively.
NOTE 10 – DEVELOPMENT PARTNER ARRANGEMENTS
License Agreements
On October 16, 2015, Legacy PCT entered into a patent license agreement with P&G (the “Original Patent License Agreement”). Legacy PCT and P&G entered into an Amended and Restated Patent License Agreement on July 28, 2020 (the “Amended and Restated Patent License Agreement”). PCT and P&G entered into a side letter agreement on February 12, 2021 amending certain provisions of the Amended and Restated License Agreement (the “Side Letter Agreement” and, together with the Original Patent License Agreement and the Amended and Restated Patent License Agreement, the “License Agreement”). The License Agreement outlines three phases with specific deliverables for each phase. During Phase 1 of the License Agreement, P&G provided Legacy PCT with up to one full-time employee to assist in the execution of Legacy PCT’s research and development activities. During Phase 2, P&G provided up to two full-time employees to assist in the execution of Legacy PCT’s research and development activities. In April 2019, Legacy PCT elected to enter into Phase 3 of the License Agreement and prepaid a royalty payment in the amount of $2.0 million, which will be reduced against future royalties payable as sales occur. Phase 3 of the License Agreement relates to the commercial manufacture period for the manufacture of the licensed product. This phase includes the construction of the first commercial plant for the manufacture of the licensed product, details on the commercial sales capacity and the pricing of the licensed product to P&G and to third parties. Where the Company has made royalty payments to its product development partners, the Company expenses such payments as incurred unless it has determined that is it probable that such prepaid royalties have future economic benefit to the Company. In such cases prepaid royalties will be reduced as royalties would otherwise be due to the partners.
Effective April 1, 2023, the Company and P&G executed a Second Side Letter, dated March 27, 2023, amending the date by which commercial sales must be maintained at 70% of nameplate capacity under Section 4.4 of the License Agreement from April 15, 2023 to December 31, 2024.
As of September 30, 2023 and December 31, 2022, the Company is in Phase 3 of the License Agreement and has recorded $2.0 million within prepaid expenses and other non-current assets in the condensed consolidated balance sheets.
On November 13, 2019, Legacy PCT entered into a patent sublicense agreement with Impact Recycling Limited (“Impact”) through the term of the patents. The agreement outlines an initial license fee of $2.5 million and royalties on production using the license. In 2020, Legacy PCT paid $0.9 million of the initial license fee, and during the year ended December 31, 2021, the Company paid the remaining $1.6 million of the initial fee. The initial license fee of $2.5 million is recorded in prepaid expenses and other non-current assets in the condensed consolidated balance sheets and will be ratably amortized over the term of the underlying patent using the straight-line method. In May
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
2021, the Company began using the technology covered by the Impact agreement and commenced amortization as of this date.
Block and Release Agreement
On June 23, 2020, Legacy PCT entered into a block and release agreement with Total Petrochemicals & Refining S.A./N.V. (“Total”). Upon execution of the agreement, Total made a prepayment consisting of a payment of $5.0 million for future receipt of resin consisting of recycled polypropylene. The prepayment was placed in an escrow account until the “release condition” of the Company closing the bond offering and overall capital funding of at least $370.0 million has occurred. After the Company successfully raised the required capital, the $5.0 million was released to the Company in 2021 and recorded as deferred revenue in the condensed consolidated balance sheets.
Strategic Alliance Agreement
On December 13, 2018, Legacy PCT entered into a strategic alliance agreement with Nestle Ltd. (“Nestle”), which expires on December 31, 2023. Upon execution of the agreement, Nestle committed to provide $1.0 million to fund further research and development efforts. The funding provided by Nestle may be convertible, in whole or in part, into a prepaid product purchase arrangement at Nestle’s option, upon the time of product delivery beginning in 2022. Additionally, because the research and development efforts were not successful as of December 31, 2020, up to 50% of the funding may be convertible into a 5-year term loan obligation, payable to Nestle at an interest rate equivalent to the U.S. prime rate. As of the issuance of these statements, Nestle has not elected to convert any funding into a term loan.
PCT received the funding from Nestle on January 8, 2019. The Company has recorded $1.0 million as a deferred research and development obligation within other non-current liabilities in the condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022. Recognition related to the funding received will be deferred until it is probable that Nestle will not exercise their option. If the prepaid product purchase option is exercised, the obligation will be recognized as an adjustment to the transaction price of future product sales (e.g., net revenue presentation). If the option is not exercised, or in the case of development efforts not being successful, any amounts not converted to a loan obligation will be recognized as a reduction to research and development costs.
NOTE 11 - INCOME TAXES
The Company has determined that any net deferred tax assets are not more likely than not to be realized in the future, and a full valuation allowance is required. In addition, the Company has determined that any current forecasted operations would result in federal and state income tax losses which are also not more likely than not to be realized. As a result, for the periods ended September 30, 2023 and 2022, the Company has reported tax expense of $0 and $0, respectively.
Management has evaluated the Company’s tax positions and has determined that the Company has taken no uncertain tax positions that require adjustment to the condensed consolidated interim financial statements for the respective periods.
NOTE 12 – FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and sets out a fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Inputs are broadly defined as assumptions market participants would use in pricing an asset or liability. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
PureCycle Technologies, Inc.
NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — CONTINUED
(Unaudited)
Level 2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly, and fair value is determined through the use of models or other valuation methodologies
Level 3 - Inputs are unobservable for the asset or liability and include situations where there is little, if any, market activity for the asset or liability. The inputs into the determination of fair value are based upon the best information in the circumstances and may require significant management judgment or estimation.
Assets and liabilities measured and recorded at Fair Value on a recurring basis
As of September 30, 2023 and December 31, 2022, the Company’s financial assets and liabilities measured and recorded at fair value on a recurring basis were classified within the fair value hierarchy as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| September 30, 2023 | | December 31, 2022 |
| Level 1 | Level 2 | Level 3 | Total | | Level 1 | Level 2 | Level 3 | Total |
Assets | | | | | | | | | |
Cash equivalents | $ | 60,349 | | $ | 129,261 | | $ | — | | $ | 189,610 | | | $ | 51,250 | | $ | — | | $ | — | | $ | 51,250 | |
Restricted cash equivalents - current | 33,277 | | — | | — | | 33,277 | | | 68,850 | | — | | — | | 68,850 | |
Restricted cash equivalents - noncurrent | 151,513 | | — | | — | | 151,513 | | | 94,781 | | — | | — | | 94,781 | |
Investments: | | | | | | | | | |
Commercial paper, available for sale | — | | 9,866 | | — | | 9,866 | | | — | | 32,756 | | — | | 32,756 | |
Corporate Bonds, available for sale | — | | — | | — | | — | | | — | | 58,442 | | — | | 58,442 | |
US Treasury Notes, Available for sale | |